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L-pipecolic acid (L-PA), a six carbon imino acid, is an intermediate of lysine 
metabolism in various organisms including bacteria, yeast, fungi, and mammals.  In 
mammals, L-PA catabolism is unusual in that two flavin dependent enzymes have 
evolved for this process.  In primates, the enzyme involved in L-PA degradation, L­
pipecolate oxidase (L-PO), has been purified and characterized as a membrane-associated, 
peroxisomal oxidase possessing a covalent flavin and producing H202. In lower mammals, 
L-PA degradation is catalyzed by a soluble, mitochondrial dehydrogenase, but little is 
known about this enzyme from any source. This thesis describes the partial purification 
and characterization of L-pipecolic acid dehydrogenase (L-PADH) from rabbit kidney 
cortex and compares physical and catalytic properties of the rabbit dehydrogenase with 
those of the primate oxidase. 
L-PADH has been purified 300 fold from rabbit kidney cortex.  The standard 
purification  procedure  included  homogenization  followed  by  DEAE-cellulose 
chromatography and 45% ammonium sulfate precipitation.  Chromatography on a 
Sephadex  G-150  size  exclusion  column  preceded  hydrophobic  interaction 
chromatography with butyl Sepharose. After dialysis, DEAE Fast Flow chromatography 
resulted in a final specific activity of 400 nmolmg" 
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at C-6, it was determined that L-PADH abstracts the pro-6R hydrogen of L-PA. 
Sixteen analogs of L-PA were tested as substrates and inhibitors of L-PADH. 
Unsaturated and sulfur containing analogs provided the best alternate substrates of L­
PADH. Nitrogen substituted, oxygen and nitrogen containing analogs served as poor 
substrates or were not oxidized by L-PADH.  Of these sixteen L-PA analogs, no 
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CHAPTER I 
BACKGROUND 
DISCOVERY OF L-PIPECOLIC ACID 
L-Pipecolic acid (L-PA), 2-carboxypiperidine (Figure I. 1), was first isolated from 
the non-protein nitrogenous fractions of Phaseolus vulgarius.1 L-PA has been found 
extensively in leguminous plants such as green beans and clover as well  as apples and 
hops.2-5 Chromatographic fractions from extracts of wheat flour and certain algae groups 
were also found to contain L- PA.6'7 
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Figure I.1 Structure of L-pipecolic acid (L-PA). 
As L-PA became recognized as a prominent biochemical constituent in many plant 
species, investigations on the origin and metabolic relationships of L-PA became 
important. The highest levels of L-PA were found concentrated in the seeds of plants and 
it was suggested that L-PA may serve as a reserve form of nitrogen.8 The origin of L-PA 
was elucidated by supplying [6-14q-lysine to P. vulgarius and discovering the L-PA 
subsequently extracted contained radioactivity.8 It was concluded from this experiment 
that L-PA also functions as an intermediate in the degradation of lysine. 2 
LYSINE BIOSYNTHESIS
 
Lysine is an essential amino acid for many animal species and is therefore required 
in the diet. Two pathways for the biosynthesis of L-lysine exist.  Green plants and 
bacteria synthesize L-lysine from L-aspartate via the diaminopimelate pathway (Scheme 
1.1).9  The number of reactions involved in the conversion of L-aspartate to meso­
diaminopimelate is species dependent. Decarboxylation of meso-diaminopimelate by 
diaminopimelate decarboxylase yields L-lysine. 
L-Lysine biosynthesis in bacteria and plants: 
5 or 8 steps  Diaminopimelate 
H2N  ,H (species  dependent) H2 N  Hz 2  H  Decarboxylase  H2N H 
HO 
CO2H  HO2c/\X CO2H  ),  HO2C)NH2 
L-Lysine L-Aspartate  meso-Diaminopimelate  CO2 
Scheme I.1 
In lower eukaryotes, e.g., yeast and fungi, L-lysine is synthesized via the a­
aminoadipate pathway (Scheme I.2).10 L-Saccharopine is the key intermediate of this 
pathway and is produced by the condensation of L-a-aminoadipate-8-semialdehyde (a-
ASA) and L-glutamate. L-Saccharopine is oxidized to L-lysine in a nicotinamide adenine 
dinucleotide (NAD+)-dependent reaction catalyzed by saccharopine dehydrogenase. 
DEGRADATION OF LYSINE 
Two pathways have evolved for the degradation of lysine in mammals and these 
are diagrammed in Scheme 1.3. Initially, Rothstein and Miller proposed that L-PA was an 
intermediate in the major pathway for lysine degradation.11 In support of this theory, 
rats that were injected with radiolabeled lysine were found to excrete radiolabeled L-PA.11 
This hypothesis was further strengthened by evidence that the a-amino group of lysine __ 
3 
L-Lysine biosynthesis in yeast and fungi: 
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was lost during the degradation process.12 The removal of the a-amino group was not 
consistent with a saccharopine intermediate (Scheme 1.2). 
In later studies, Higashino and coworkers incubated uniformly labeled L-[14C]­
lysine with rat liver homogenates and discovered that a-ketoglutarate was required for the 
emission of 14CO2.13 Furthermore, labeled saccharopine was detected indicating that the 
saccharopine pathway is operational during L-lysine degradation. Additional studies in 
rabbits provided further proof of the importance of the saccharopine pathway. In rabbits 
the production of 14CO2 from L- [14C]- lysine was reduced by the addition of L-a­
aminoadipate (a-AAA), but not L-PA.14 The negligible effect of L-PA on the reduction 
14CO2 CU emission indicated that L-PA was not an intermediate in L-lysine degradation. It 
was thus concluded that the primary route of L-lysine degradation occurred via 
saccharopine.14  In humans, dogs and mice the saccharopine pathway has been 
determined to be the predominant route of L-lysine metabolism.15-17 It is interesting to 
note that the major degradation pathway of lysine in animals is the reversal of the L-a­
aminoadipate biosynthetic pathway found in yeast in fungi.18,19 D-Lysine 
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L-PIPECOLIC ACID PATHWAY
 
Although the L-PA pathway was not found to be the major route of L-lysine 
degradation, it was important to determine what role the L-PA pathway plays in lysine 
degradation. To elucidate the pathway further, Grove and Henderson incubated rat liver 
homogenates with D-[14C6]-lysine and subsequently detected high levels (40% of the total 
radioactivity) of radiolabeled L-PA whereas a-AAA was detected at much lower levels 
(0.02% of the total radioactivity).20 Incubation of the liver homogenate with L-[14C6]­
1ysine did not produce radiolabeled L-PA. Further investigation revealed that the removal 
of the a-amino group only occurred in the conversion of D-lysine to L-PA and it was 
concluded that the production of L-PA in the liver occurred by the degradation of D­
lysine.21 
Even though the conversion of D-lysine to L-PA was documented in rat liver, the 
intermediates of the pathway had not been characterized. The conversion of D- and L-
lysine to a-keto-e-aminocaproic acid rather than a-ASA was elucidated using specifically 
labeled 15N lysine.21 Furthermore, D-amino acid oxidase had been detected in liver and 
shown to convert D-lysine to a-keto-E-aminocaproic acid.22  It was also demonstrated 
that a-keto-E-aminocaproic acid was in equilibrium with the cyclic imine form, A1­
piperideine-2-carboxylic acid (A1-P2C).23 Finally, A1-P2C was stereospecifically reduced 
by a NADH-dependent reductase producing L-PA.24 
Even though L-lysine is primarily degraded through the saccharopine pathway in 
the liver, it is interesting to note that in the brain the saccharopine pathway enzymes are 
not detected.25,26  Instead, L-lysine has been shown to be degraded to L-PA in the 
brain.27 These studies suggest that the L-PA pathway is the major route of L-lysine 
degradation in the central nervous system (CNS).28 The conversion of L-lysine to a­
keto -E- aminocaproic acid has been indicated by the detection of A1-P2C, however, the 
enzyme in the CNS responsible for this conversion has not been isolated.24 
The formation of L-PA was demonstrated in the liver and brain, however the 
intermediates in the degradation of L-PA to a-AAA had not been identified.  In the 
1960's Rodwell and coworkers examined pipecolic acid metabolism in the soil 
microorganism Pseudomonas putida. Studies of L-PA metabolism were carried out in P. 
putida because L-PA could be supplied as the sole source of carbon and nitrogen.29 The 
oxidation of L-PA by P. putida resulted in the formation of a-AAA, suggesting a close 
similarity to the pathway postulated for the mammalian system.  Studies on P. putida 
grown in the presence of L-PA and bisulfite resulted in the isolation of two new 
compounds, A1-piperideine-6-carboxylic acid (A1-P6C) and a-ASA.30 It was suggested 6 
that Al-P6C and a-ASA were intermediates in the conversion of L-PA to a-AAA. 
Further investigation showed that a-AAA was subsequently converted to glutamate.31 
The enzyme required for the oxidation of L-PA to A'-P6C in P. putida was 
isolated and partially characterized. The protein was shown to be a flavin-requiring 
membrane-bound dehydrogenase associated with electron transport components.32 The 
enzyme involved in the conversion of a-ASA to a-AAA, the second step in the 
degradation of L-PA, was shown to be nicotinamide adenine dinucleotide phosphate 
(NADP+)-dependent.33 These observations support the L-PA degradation pathway 
shown in Scheme 1.3. 
PHARMACOLOGICAL ROLE OF L-PIPECOLIC ACID 
Lysine is metabolized specifically to L-PA in the brain of humans, dogs, rats, mice 
and ChiCkS.27'28'34'35  Because the L-PA pathway is the major pathway for the 
degradation of lysine in the CNS, the potential neurological significance of L-PA was 
studied.  L-PA has been shown to have a neuromodulatory role on GABAergic 
neurotransmission.36 Elevated levels of L-PA have also been associated with Zellweger 
syndrome and familial hyperlysinemia, both of which are associated with severe cerebral 
dysfunction.37-39 Further study of the  enzymes involved in the L-PA pathway may 
provide insight into the role of L-PA in these diseases. 
L-PIPECOLIC ACID OXIDATION 
The specialized role of L-PA metabolism in many organisms spurred further 
investigation of the pathway. The oxidation of L-PA has been investigated in a variety of 
species. In the bacterium, P. putida, the oxidation of L-PA to a-ASA is catalyzed by a 
flavin adenine dinucleotide (FAD) requiring membrane-bound dehydrogenase associated 
with an electron transport particle.32 In the lower eukaryote Rhodotorula glutinis,  a red 
yeast, L-PA is metabolized by a soluble oxidase which requires molecular oxygen and 
produces H202.4° This enzyme has been partially purified and reported to require no 
external cofactor, and was suggested to be linked to an internal electron exchange 
system.40,41  In Neurospora crassa, L-PA oxidation is predicted by the observed 
conversion of D-lysine to L-lysine via L-PA (Scheme 1.4).42 7 
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Scheme 1.4 
This same pathway is thought to operate in the green plant Nicotiana glauca based on 
similar observations.43,44 These diverse organisms serve as useful comparative models 
for detailed studies of L-PA oxidation in mammalian systems. 
Early studies on the oxidation of L-PA were conducted in rats, an animal which 
excretes, rather than degrades, L-PA.16 This animal model chosen for these studies may 
explain the early lack of information on the L-PA pathway in mammals.  Later 
investigations on the subcellular metabolism of L-PA was carried out on nine species of 
mammals as summarized in Table 1.1.45-49  L-PA oxidation was localized in the 
mitochondria in the rabbit, guinea pig, dog, pig and sheep.46 Initially no L-PA oxidation 
was detected in the rat and mouse.46 A more sensitive assay was developed and it was 
shown in rats that L-PA was degraded in the mitochondria and peroxisomes.50 In 
primates L-PA was oxidized in the peroxisomes.47,48 8 
Table I.1 Organellular location of L-PA oxidation in mammals. 
Species 
Rabbit 
Guinea Pig 
Dog 
Pig 
Sheep 
Monkey 
Human 
Mouse 
Rat 
Mitochondria 
+ 
+ 
+ 
+ 
+ 
+ 
Peroxisomes 
+ 
+ 
+ 
Further investigation lead to the discovery that the highest level of L-PA oxidation 
was in the mitochondria of rabbit kidney cortex and peroxisomes of monkey liver.45 A 
comparison of the mitochondrial and peroxisomal metabolism of L-PA was conducted in 
the rabbit and cynomolgus monkey and is summarized in Table 1.2.45 
Table 1.2 Comparison of rabbit and monkey metabolism of L-PA. 
Characteristic 
Tissue with highest activity 
Subcellular location 
Reaction product detected 
Specificity 
Kapp n 
Effect of: 
FAD 
PES 
Antimycin A 
Rabbit 
Kidney Cortex 
Mitochondria 
a-Aminoadipic Acid 
L-Pipecolic Acid 
0.74 mM 
Enhances 
Enhances 
Inhibits 
Monkey 
Liver 
Peroxisomes 
a-Aminoadipic Acid 
L-Pipecolic Acid 
4.22 mM 
None 
Inhibits 
None 
The final product of L-PA degradation detected in both tissue preparations was 
a-AAA. In both the rabbit and the monkey the oxidative activity was highly specific for 
L-PA, however the monkey preparation exhibited a six fold higher Km for the substrate. 9 
The addition of FAD and an artificial electron acceptor, phenazine ethosulfate (PES), 
enhanced the activity in the rabbit preparation. The activity from the rabbit preparation 
was inhibited by antimycin A, an electron transport chain inhibitor. This suggests that 
the electrons from the oxidation of L-PA are eventually shuttled to the electron transport 
chain and is consistent with the location of the enzyme in the mitochondria. 
Recently, the primate enzyme catalyzing the oxidation of L-PA was isolated and 
characterized from Rhesus monkey liver.47 L-pipecolic acid oxidase (L-PO) was shown 
to be a peroxisomal membrane-associated monomer with a molecular weight of 46 kDa, a 
pI of 8.9 and to contain a covalently bound flavin exhibiting absorption maxima at 457 
and 383 nm with a shoulder at 480 nm. 
Little is known about the mitochondrial dehydrogenase from any of the 
previously mentioned sources. The following chapters describe progress toward the 
purification and characterization of L-pipecolic acid dehydrogenase (L-PADH) from 
rabbit kidney cortex. 10 
CHAPTER II
 
PARTIAL PURIFICATION AND CHARACTERIZATION OF L-PIPECOLIC ACID
 
DEHYDRO GENA SE 
INTRODUCTION 
Chapter I discussed the similarities and differences of the various known enzymes 
involved in the oxidation of L-pipecolic acid. Among mammals, the organellular location 
of L-PA oxidation was shown to be species dependent.46  The primate enzyme 
responsible for the oxidation of L-PA was determined to be a membrane-associated 
peroxisomal oxidase possessing a covalent flavin and producing H202.45,47 Initial studies 
by Mihalik and Rhead revealed that in lower mammals the enzyme was a soluble 
mitochondrial dehydrogenase requiring a flavin cofactor as well as an artificial electron 
acceptor. 45 
The peroxisomal oxidase has been purified and characterized from Rhesus monkey 
liver.47 L-Pipecolic acid oxidase (L-PO) was determined to be a 46 kDa monomer, with a 
pH optimum of 8.5, a pI at 8.9 and a Km of 3.7 inM with a Vmax of 2.1 iimolmin-1mg-1 
for the natural substrate, L-PA. The mitochondrial dehydrogenase has not been isolated 
from any mammalian source and the one of the goals of this project was to purify to 
homogeneity and fully characterize the enzyme.  This chapter describes the partial 
purification and characterization of L-pipecolic acid dehydrogenase from rabbit kidney 
cortex. 
MATERIALS AND METHODS 
Materials. All biochemicals were purchased from Sigma, Fisher or VWR. All 
buffers and solutions were prepared using double deionized (NANOpure, Barnstead) and 
filtered (0.45 iim) water. D,L- [2,3,4,5,6 -3H]- pipecolic acid was custom synthesized by 
Amersham. Sodium boro[3H]hydride was purchased form Dupont NEN. UniverSol 
scintillation cocktail was purchased from ICN. Radioactivity was detected on a Beckman 
LS 6000SC or a Beckman LS 6800 liquid scinitillation counter. Frozen rabbit kidney 
cortexes were obtained from Pel-Freez Biologicals. DEAE Fast Flow, butyl, octyl and 11 
phenyl Sepharose® was purchased from Pharmacia. Dowex 50W-X8 (100-200 mesh, II+ 
form), gel filtration standards, protein A Sepharose®, Sephadex® G-150, G-100 and G-75 
were from Sigma. Acrylamide, gel silverstaining kit, goat anti-rabbit IgG, hydroxylapatite, 
AG 1X (100-200 mesh, acetate form), Mono S and Mono Q column chromatography 
resins were obtained from BioRad. Toyopearl® phenyl and ether resins were purchased 
from TosoHaas. The perfusion chromatography resins, polyethyleneimine (PI) and 
phenyl (HP2), were from PerSeptive Biosystems. Perfusion chromatography analysis by 
HPLC was carried out on a Beckman BioSys 510 System. Spectrophotometric studies 
were performed using a Hitachi U2000 spectrophotometer.  DEAE-cellulose 
chromatography resin, silica gel and reverse phase (C18) thin layer chromatography 
(TLC) plates were purchased from Whatman. HPLC analysis was carried out on a 
Beckman System Gold System using a 4.6 x 100 mm (3  reverse phase (C18) column 
(Microsorb MV, Rainin). Dialysis cartridges were obtained from Pierce. The antisera for 
the primate oxidase was a gift from Prof. Stephanie J. Mihalik (Johns Hopkins 
University). 
L-12,3,4,5,6-31-1J-Pipecolic acid:  2-Pyridinecarboxylic acid was catalytically 
reduced with tritium gas by Amersham. The resulting D,L- [2,3,4,5,6 -3H]- pipecolic acid 
(D,L- [3H] -PA) had a specific activity of 6200 mCi/mmol and was separated from its 
radiolytic degradation products and converted to the homochiral L-form by the method of 
Mihalik and Rhead.45 D,L431-11-PA (7 mCi) was applied to a sequential anion exchange ­
cation exchange chromatography system in which the upper column consisted of 1 mL 
(0.5 x 5 cm) of AG1-X8 anion exchange resin and the lower column consisted of 20 mL 
(1.5 x 11 cm) Dowex 50W-X8 cation exchange resin.45 Both columns were washed with 
55 mL ddH2O, until no further radioactivity was eluted. The cation exchange column was 
washed with 80 mL of 0.5 N HC1 and then the D,L- [3H] -PA was eluted with 2 N HC1. 
Fractions containing radioactivity were pooled and concentrated to dryness on a rotary 
evaporator. The residue was resuspended in 10 mL of ddH2O and brought to pH 6 with 
6 M NH4OH. The material was then applied to a 110 mL (2.5 x 22 cm) Dowex 50W-X8 
column and washed with 250 mL of ddH2O. The D,L- [3H] -PA was eluted with 1 M 
NH4OH and concentrated to dryness. The solid was resuspended in 10 mL of ddH2O 
and then dried again. This process was repeated five additional times for a total of six 
washes. The purified D,L- [3H] -PA was dissolved in 3 mL of 0.1 M sodium phosphate 
buffer, pH 8.0, and brought to a specific activity of 500 Ki/limol with unlabeled L­
pipecolic acid.  After adding 4.8 units of D-amino acid oxidase (D-AAO) and 7.4 mM 
NaBH4, the reaction was stirred at 37 °C for one hour, at which time the same amounts of 
D-AAO and NaBH4 were added and the reaction continued for another two hours. The 12 
reaction converts the D-enantiomer to the L-enantiomer by stereospecifically oxidizing D­
PA to A1-piperideine-2-carboxylate (.6,1-P2C) while L-PA is unaffected. The 6,1-P2C is 
then reduced with NaBH4 to form D,L- [3H]- pipecolic acid. By continuously repeating 
the oxidation and reduction cycle, D-PA can be quantitatively converted to L-PA.51 L­
[3H]-Pipecolic acid is separated from the reaction mixture using an 85 mL (2.5 x 17 cm) 
Dowex 50W-X8 cation exchange column. After washing the column with 135 mL of 
ddH2O, the L-[311]-PA was eluted with 1 M NH4OH, concentrated to dryness, and was 
subsequently washed with 10 mL of ddH2O. The conversion of D,L441]-PA to L-[31-1]­
PA was checked for completeness by incubating 0.5 units of D-AAO with 1 111. of the 
converted L-[31-1]-PA mixture (0.8 mM) in 0.1 M sodium phosphate, pH 8.0, along with 
8,000 units of catalase. If any significant amount of the D-enantiomer was present, the 
release of 3HOH should be observed. No 3HOH was detected when the D-AAO reaction 
mixture was applied to a cation exchange column and the unretained fraction was analyzed 
for radioactivity. L- [3H]- Pipecolic acid was stored at -86 °C at a concentration of 10 mM 
and a specific activity of 500 [1.Ci/limol. 
Enzyme assay.  The enzymatic oxidation of L-pipecolic acid was measured 
through the release of 3HOH from L- [2,3,4,5,6 -3H]- pipecolic acid (L- [3H]- PA).45 
Fifteen tL aliquots of the enzyme fractions were incubated for one hour at 37 °C in an 
assay mixture containing 12 mM Tris, 5 mM KCI, 0.1 mM FAD, 1.0 mM PES, and 62.5 
tM L-[31-1]-PA (125 1.1Ci/p.mol) at pH 8.5 in a total volume of 60 lit. The reaction was 
halted by placing the tubes on ice. The assay mixture was applied to a Dowex 50W-X8 
cation exchange column (0.8 mL) and the column was washed with 4.5 mL of ddH2O. 
The collected water was mixed with 10 mL of scintillation cocktail and the radioactivity 
was measured in a liquid scintillation counter (LSC). 
Protein dependence. L-PADH was incubated at 37 °C in the above assay mixture 
at final protein concentrations of 7.8, 5.2 and 2.6 mg/mL. For each of the three different 
protein concentrations duplicate assays were performed and the amount of 3HOH 
produced was measured at 15, 30 and 45 minutes. 
Effect of unlabeled L-PA on radioassay. 90 tg of L-PADH was incubated at 37 
°C in assay mixtures containing 12 mM Tris, 5 mM KC1, 0.1 mM FAD, 1.0 mM PES 
with final concentrations of L-PA of 64 tM (1251.1Ci/mol), 320 p.M (25 p.Ci/i_tmol), and 
640 [tM (12.5 Ki/mol). For each of the different L-PA concentrations duplicate assays 
were conducted and the amount of released 3HOH was measured at 15, 30, 45 and 60 
minutes. 
pH Dependence. Fifteen [1.1, aliquots of an active L-PADH fraction from a 
Sephadex® G-150 column were incubated for one hour at 37 °C in 25 mM buffer 13 
(morpholinoethanesulfonic acid (MES), bis tris propane (BTP), and potassium carbonate) 
at various pH values along with 0.1 mM FAD, 1.0 mM PES, and 62.5 1.1M L-[31-1]-PA 
(125 Ki/i_tmoi) in a total volume of 60 pt. The reactions were halted by placing the 
reactions on ice and the amount of 3HOH produced was determined as described above. 
Partial purification. All steps were carried out at 4 °C unless otherwise specified. 
In a typical preparation 100 g of frozen, mature rabbit kidney cortexes were partially 
thawed and finely minced with a razor blade.  The tissue was added to 200 mL of 
preparation buffer (10 mM KC1, 50 mM N-(2-hydroxyethyl)piperazine-N'­
ethanesulfonic acid (HEPES), pH 7.4, 0.1 mM ethylenebis(oxyethylenenitrilo)tetraacetic 
acid (EGTA), and 0.1 mM phenylmethylsulfonyl fluoride (PMSF)) and the slurry was 
homogenized by two passes with a Potter-Elvehjem homogenizer. The homogenate was 
centrifuged at 800 x g for 10 minutes and the supernatant decanted and centrifuged at 
27,000 x g for 30 minutes. The pellet was discarded and the cell free supernatant was 
applied at a rate of 2 mL/min to a DEAE-cellulose column (5 x 8 cm) equilibrated in 10 
mM KC1, 50 mM HEPES, pH 7.4, and 0.1 mM EGTA. The column was washed with 
the equilibration buffer and bound protein was eluted at 2 mL/min using a step gradient cf 
increasing concentration of KC1 in 50 mM HEPES, pH 7.4, 0.1 mM EGTA. Fractions 
were assayed for L-PADH activity which typically eluted between 75 mM and 150 mM 
KC1. The active fractions were pooled and subjected to ammonium sulfate precipitation 
by the slow addition of ammonium sulfate to 45% saturation. The solution was allowed 
to equilibrate for 30 minutes while stirring and then centrifuged at 27,000 x g for 30 
minutes. The resulting pellet was suspended in a minimal amount of 250 mM KC1, 50 
mM potassium phosphate, pH 7.4, 10% glycerol. This material was chromatographed on 
a Sephadex® G-150 size exclusion column (2.5 x 110 cm) equilibrated in 250 mM KC1, 50 
mM potassium phosphate, pH 7.4, at a flow rate of 0.4 mL/min. L-PADH activity began 
eluting after 350 mL. The active fractions were pooled and adjusted to 1 M ammonium 
sulfate. This material was applied to a butyl Sepharose® column (1.5 x 3 cm) equilibrated 
in 1 M ammonium sulfate, 50 mM HEPES, pH 7.4, at a flow rate of 1 mL/min. Using a 
step gradient, the highest specific activity of L-PADH eluted between 0.75 M and 0.5 M 
ammonium sulfate.  Fractions containing high L-PADH activity were pooled and 
concentrated by centrifugation (5,000 x g) using an Amicon Centriprep ultrafiltration 
device with a 10 kDa molecular weight cutoff. The concentrated sample (2 mL) was then 
dialyzed overnight against a low salt buffer (500 mL of 10 mM KC1, 50 mM HEPES, pH 
7.4), using a dialysis cartridge with a molecular weight cutoff of 10 kDa. The dialysate 
was applied to a DEAE Fast Flow column (1.5 x 2.5 cm), equilibrated in dialysis buffer, 
at a rate of 3 mL/min. The column was washed with dialysis buffer and bound protein 14 
was eluted using a linear gradient of increasing KCl concentration from 10 mM to 200 
mM. The active fractions were pooled and concentrated by ultrafiltration. 
Protein concentration. During purification, protein quantification was determined 
by the method of Bradford.52 A standard curve was produced by using known 
concentrations of BSA at 0, 0.1, 0.375, 0.50, 0.75, and 1.0 mg/mL. 
SDS-PAGE analysis. Sodium dodecylsulfate-polyacrylamide gel electrophoresis 
(SDS-PAGE) analyses were carried out using a BioRad Mini-Protean II system. Buffers 
for a 12.5% resolving gel and a 4% stacking gel were based on the method of Laemmli.53 
SDS-PAGE sample loading buffer contained 62.5 mM Tris, pH 6.8, 10% glycerol, 2% 
SDS, 15% 0-mercaptoethanol and 0.005% bromophenol blue. Tank buffer consisted of 5 
mM Tris, pH 8.3, 38 mM glycine and 0.02% SDS.  Denaturing gels were run at constant 
voltages of 100 V through the stacking gel and 200 V through the resolving gel. 
Gel staining. Gels were stained in 3 mM Coomassie brilliant blue R, 40% Me0H, 
and 10% HOAc. Protein bands were visualized by destaining in an aqueous solution 
containing 40% Me0H and 10% HOAc. Silver stained gels were developed using the 
silver staining kit from BioRad. 
Mitochondria isolation.54 Frozen rabbit kidney cortexes (25 g) were finely minced 
and homogenized in 75 mL of 250 mM sucrose, 6.8 mM HEPES, pH 7.5, 0.1 mM 
EGTA. The slurry was centrifuged at 3,200 x g for one minute, the supernatant decanted 
and centrifuged for two minutes at 17,000 x g.  The pellets were washed with the same 
buffer and centrifuged for 4.5 minutes at 19,000 x g.  The floculent pellets were 
resuspended in homogenizing buffer and exposed to a freeze/thaw procedure to break 
open the mitochondrial membrane. The mixture was rapidly frozen by submersion into a 
dry ice and acetone bath and then rapidly thawed in a 37 °C H2O bath. This technique 
was repeated several times. The mixture was centrifuged at 45,000 x g for one hour. The 
resultant supernatant and pellet were assayed for glutamate dehydrogenase activity. 
Glutamate dehydrogenase assay.54  The assay mixture contained 50 mM 
potassium phosphate, pH 8.0, 0.12 mM NAD+, and 30  mM potassium glutarate. The 
reduction of NAD+ was monitored at 340 nm. L-Glutamate dehydrogenase purchased 
from Sigma was used as a standard. 
Native molecular weight. A 160 mL Sephadex® G-100 column (1.5 x 90 cm) was 
calibrated according to the manufacturers directions in 50 mM potassium phosphate, pH 
7.4, 250 mM KCI, at a flow rate of 0.33 mL/min.  Blue dextran was used to determine the 
void volume (V0) of the column. The molecular weight standards included bovine serum 
albumin, alcohol dehydrogenase, carbonic anhydrase, 0-amylase and cytochrome C. Each 
sample mixture was loaded in a 2 mL volume containing 50 mM potassium phosphate, 15 
pH 7.4, 250 mM KC1, 5% glycerol and the elution volumes (Ve) were measured at the 
point where the UV absorbance (280 nm) was greatest. The log of the molecular weight 
was plotted versus the ratio of the elution volume and the void volume. A calibrated 
Sephadex® G-75 column was also used to estimate the native molecular weight using the 
same buffer and a flow rate of 0.2 mL/min. Blue dextran was used to measure Vc, and four 
molecular weight standards were applied in 2 mL of the same loading buffer.  The 
molecular weight standards included bovine serum albumin, cytochrome C, carbonic 
anhydrase and aprotinin. A sample of partially purified L-PADH (1.5 mg) was analyzed 
on each column and the Ve was measured at the point where the specific activity was 
highest. 
Native gel electrophoresis: Native gel electrophoresis was carried out following 
the procedure of Ornstein and Davis.55,56  Slab gels were run using a BioRad Mini-
Protean II system. The gel buffer was comprised of 0.5 M Tris, pH 6.8, for the 4% 
stacking gel, and 1.5 M Tris, pH 8.8, for the 6% and 10% resolving gels. The tank buffer 
contained 25 mM Tris, pH 8.8, 192 mM glycine, and the sample loading buffer contained 
32 mM Tris, pH 6.8, 5% glycerol and 0.005% bromophenol blue. 
The Jovin buffer system was also tried.57 The Jovin system is a discontinuous 
system in which the cathode buffer was comprised of 50 mM HC1 and 63 mM bis tris, 
pH 7.4, and the anode buffer contained 44 mM TES and 110 mM bis tris, pH 7.25. The 
gel buffer contained 0.5 M BisTris, 9.22 M HC1, pH 6.6 and the sample loading buffer 
contained 125 mM BisTris, pH 6.61, 5% glycerol, and 0.005% of bromophenol blue. 
A continuous buffer system described by McLellan in which the gel buffer is the 
same as the tank buffer (250 mM Tris, 125 mM boric acid, pH 8.7) was also used.58 The 
sample loading buffer also contained 5% glycerol and 0.005% bromophenol blue. 
All gels dimensions were 5 x 7.4 x 0.075 cm, unless otherwise indicated. Prior to 
loading protein samples, all native gels were run at 25 V for one hour in buffer containing 
sodium thioglycolate (11 mg/L) to remove any residual radical species.59 The gels were 
run at 4 °C at constant voltage (25 V) for the length of time specified in the Results 
section. The gels were sliced horizontally and divided into sections for staining, assaying, 
and SDS-PAGE analysis (Scheme II.1). 
The silver stained section was treated according to the BioRad silver staining kit 
instructions. The slices to be assayed were placed in 1.5 mL conical centrifuge tubes with 
30  of 12 mM KCI, 5 mM HEPES, pH 8.5 and mashed with a pestle. The radiolabeled 
substrate and all cofactors were added and the mixture was assayed as described above. 
The slices to be analyzed by SDS-PAGE were incubated at 96 °C for 10 min in 30 [tL, of 
SDS-PAGE loading buffer and then the slices and any extra sample buffer were loaded 16 
onto a 5 x 7.4 x 0.1 cm 12.5% acrylamide denaturing gel with a 4% acrylamide stacking 
gel. The gel was electrophoresed and silver stained as described above. 
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Scheme II.1 
Western blot analysis. Samples of L-PADH from various purification steps were 
subjected to SDS-PAGE. After electrophoresis the gel was placed in transfer buffer (25 
mM Tris, pH 8.5, 192 mM glycine, and 20% Me0H) for 15-30 min. The gel was then 
placed between a nitrocellulose membrane and filter paper and placed in a Mini Trans-
Blot® (BioRad) blotting chamber containing 450 mL of transfer buffer. The protein was 
electroblotted to the membrane at 100 V for one hour. The membrane was washed in 50 
mL of 50 mM Tris, pH 7.5, 150 mM NaC1 for 10 min. Non-fat dry milk (5 g) was added 
to the solution which was allowed to shake for one hour. The milk mixture was decanted 
and the L-PO antisera (rabbit anti-monkey antisera) was added in a dilute mixture 
(1:2000) in 15 mL of transfer buffer with 0.05% Tween 20. The membrane was shaken in 
this solution overnight at 4 °C. The membrane was rinsed three times in 20 mL of 
transfer buffer with 0.05% Tween 20. A final rinse of 15 mL of transfer buffer with 0.3% 
non-fat dry milk preceded the addition of 15 }IL (1:1000) of IgG antibody (goat anti-
rabbit conjugated with alkaline phosphatase). The membrane was shaken in this mixture 
for two hours and then rinsed three times with 20 mL of transfer buffer containing 0.05% 17 
Tween 20. The membrane was placed in 20 mL of 0.1 M Tris, pH 9.5, 0.5 mM MgC12 
and the following substrates were added to visualize bands: 200 µL of p-nitro blue 
tetrazolium chloride (NBT, 30 mg/mL in 70% aqueous dimethyl formamide (DMF)) and 
200 p.1_, of 5-bromo-4-chloro-3-indoyl phosphate p-toluidine salt (BCIP, 15 mg/mL in 
DMF). Color development was stopped by rinsing the membrane with ddH2O. 
Immunoprecipitation.  Initial studies were carried out on 0.5 mL fractions of 
partially purified L-PADH, L-pipecolate oxidase and a blank consisting of 0.5 mL of 
suspension buffer (10 mM KC1, 50 mM HEPES, pH 7.4). These fractions were added to 
0.1 mL of protein A Sepharose® (50 mg/mL in suspension buffer) and rocked at 4 °C for 
one hour. The slurries were centrifuged for one minute at 3,100 x g and the supernatants 
were decanted into 1.5 mL conical centrifuge tubes. This initial incubation was carried out 
to reduce non-specific binding particles that may interact with the protein A Sepharose®. 
L-PO antisera (rabbit anti-monkey antisera, 3 [IL) was added to the supernatants and the 
samples were then incubated on ice for 30 min. Protein A Sepharose® (0.1 mL of 50 
mg/mL in suspension buffer) was added to each and the mixtures were rocked for 2.5 
hours at 4 °C.  The mixtures were centrifuged for two minutes at 3,100 x g.  The 
supernatant was set aside and 1 mL of suspension buffer was added to the resin and 
centrifuged again. The supernatants from four consecutive washes were pooled. The 
supernatants were assayed for L-PADH activity using the radioassay. Both the resins 
and 20 µL of the supernatants were added to 20 µL of SDS-PAGE loading buffer. The 
samples were heated to 96 °C for 10 minutes. The resin mixtures were centrifuged at 
5,000 x g and the resulting supernatants were analyzed on a 12.5% SDS-polyacrylamide 
gel, along with the aliquots of the pooled supernatant washes. 
Native gel activity stain. This procedure was adapted from Witwer and Wagner.6° 
L-PADH was assayed by incubating a slice from a 6% McLellan native gel in 15 mL of 
0.1 M potassium phosphate buffer, pH 7.4, containing 0.1 M L-PA, 0.04 mM FAD, 0.2 
mM PES, and 0.5 mM NBT at 37 °C overnight. 
Isoelectric point. Isoelectrofocusing experiments were performed using a BioRad 
Rotofor Cell®. The Rotofor Cell® is a preparative isoelectricfocusing devise that has two 
different sizes of focusing chambers with membranes that divide the chambers into 20 
compartments and a internal ceramic cooling finger. Rotation of the chambers at 1 rpm 
stabilizes against gravitational forces. Ampholytes (Biolytes, BioRad) with a pH range of 
3 to 10 were used to focus L-PADH. Two different chamber sizes, one with a 60 mL 
capacity and one with a 20 mL capacity, were used. Run times and wattages for each 
experiment varied and are listed in the Results section. Glycerol (5 to 15% ) was added to 
the samples in order to maintain the solubility of the protein.  After harvesting the 18 
protein, the pH of each fraction was tested and L-PADH activity was determined using 
the radioassay. 
Kinetic parameters. A spectrophotometric assay was employed to determine the 
Km and Vmax values for the natural substrate, L-PA. This is a dye-linked assay which 
follows the reduction of dichlorophenol-indophenol (DCPIP).61 The reaction mixture 
contained 12 mM Tris, pH 8.5, 5 mM KC1, 0.1 mM DCPIP (c = 21.5 Lmmol-1cm-1), 1 
mM KCN, 0.07 mM FAD, 0.7 mM PES, and 25 1.1L of partially purified L-PADH (62 
lig) in a total volume of 0.5 mL. The reaction was initiated with substrate and the 
reaction was monitored at 37 °C as a decrease in absorbance at 600 nm. A blank 
containing all the reaction components except substrate was used in the reference cell. 
The software package Enzyme Kinetics, from Trinity Software, was used to analyze the 
data. 
Stereochemical course of the oxidation of L-PA. The stereochemical  course of the 
oxidation was studied using L-PA stereospecifically deuterated at C-6.62 The DCPIP 
assay was used to monitor the rate of the reaction using L- [6R- 2H] -PA and L- [6S- 2H] -PA 
as substrates (1 mM final concentration). 
Turn-over product characterization. 
Phenylisothiocyanate: Derivatization of the turnover product from the 
reaction of L-PADH with L-PA was attempted using phenylisothiocyanate (PITC).63 
Authentic L-PA was derivatized first to produce a standard. L-PA (2 mmol) was mixed 
with buffer (12 mM Tris, pH 8.5, 5 mM KCl) and 50% pyridine. PITC (50 4)  was 
added and the mixture incubated at 37 °C for 30 min. After incubation, 0.5 mL of 1 N 
HC1 was added and the mixture was placed on ice for one hour. A precipitate formed and 
the mixture was centrifuged for 3 min at 1,000 x g. The supernatant was set aside and the 
pellet was resuspended in 100 111, of 1.0 N HCl and analyzed by TLC on glass-back 
reverse phase plates in 1:1 0.1% TFA:CH3CN. The plate was developed with ninhydrin. 
Initial incubations were carried out with L-PO as a control because the turnover product 
has been characterized as M-P6C. L-PO was incubated overnight at 37 °C in 50 p.L 
containing 2.5 mM KC1, 2.5 mM HEPES, pH 7.4, 0.1 mM EGTA and 11.0 mM L-PA. 
L-PADH was incubated overnight at 37 °C in a total assay volume of 60 pL containing 12 
mM Tris, 5 mM KC1, 0.1 mM FAD, 1.0 mM PES, and 12.5 mM L-PA at pH 8.5. The 
solutions were brought to 50% pyridine and the derivitization procedure was carried out 
as described above. L-PO and L-PADH reaction product mixtures were analyzed by 
TLC in the aforementioned solvent system. The samples were also analyzed by reverse 
phase (C18) HPLC (4.6 x 100 mm, Microsorb MV). The column was equilibrated and run 
in 7:3 0.1% TFA:CH3CN at a rate of 1 mL/min. Peaks were detected at 270 nm. 19 
9-Fluorenylmethyl chloroformate:64 To prepare a standard, a 20 mM 
solution of L-PA was made in 50 mM potassium borate, pH 9.5.  9-Fluorenylmethyl 
chloroformate (FMOC) was diluted to 5 mM in acetone and was added to the L-PA 
solution for a final concentration of 1.3 mM. Water (1 mL) was added and the solution 
was immediately extracted twice with 2 mL of ether to remove the excess FMOC. The 
aqueous layer was concentrated to dryness and the resulting solid was dissolved in 50 lit 
of ddH2O. TLC analysis was carried out on reverse phase (C18) plates in 1:1 100 mM 
phosphoric acid:CH3CN. L-PADH was incubated at 37 °C in 50 mM borate, 0.1 mM 
FAD, 1.0 mM PES, and 6.5 mM L-PA at pH 9.5 in a total volume of 120 4. 100 4 
aliquots were taken from the enzyme mixture at time 0, 0.5, 1, 2, 4, and 8 hours and 
placed in a 1.5 mL conical centrifugation tubes. Approximately 0.3 mL of 5 mM FMOC 
was added to the reaction mixture followed by 0.3 mL of ddH2O. The solution was 
immediately extracted twice with 1 mL of ether and the aqueous layer was concentrated 
to dryness. The solid was dissolved in 50 4 of ddH2O. Reverse phase HPLC analysis 
was employed using an isocratic solvent system of 1:1 100 mM phosphoric acid:CH3CN 
on a Microsorb MV column (4.6 x 100 mm). 
Sodium borof3Mhydride reduction:65 L-PADH was incubated in 0.5 mL 
containing 12 mM Tris, 5 mM KC1, 0.1 mM FAD, 1.0 mM PES, 0.1 mM L-PA, pH 8.5, 
at 37 °C for 1.5 hours.  At this time an additional 1.0 mM PES was added and the 
reaction was allowed to continue for another hour.  After the incubation, 12 4 of (1 
NaB3H4 in 0.1 N NaOH was added to the mixture and kept at room 
temperature for 2.5 hours.  The reaction was quenched with 25 µL of 1 N HC1 and 
incubated at room temperature for 30 min. The mixture was then applied to a dual 
column system where the upper column consisted of 0.8 mL of AG lx anion exchange 
resin and the lower column contained 1 mL of AG 50W-X8 cation exchange resin. After 
the enzyme reaction mixture was added, the columns were washed with 4.5 mL of 
ddH2O. The eluant was added to 10 mL of scintillation counter cocktail and assayed for 
radioactivity. The AG 1X column was stripped with 3 mL of 1 N HOAc and the AG 
50W-X8 column was stripped with 3 mL of 1 N NH4OH.  These eluants were 
concentrated to dryness and resuspended in 20 4 of ddH2O. A 2 4 aliquot of the 
resuspended material was mixed with 5 mL of scintillation cocktail and radioactivity 
measured by LSC. TLC analysis of the resuspended solid was carried out on aluminum 
backed silica gel in 7:3 Et0H:NH4OH and developed with ninhydrin. Sections of the 
plate were cut and the silica gel was scraped off, added to 5 mL of scintillation counter 
cocktail, and analyzed by LSC. 20 
Formation of a-ASA/Bi sulfite adduct: This procedure was developed as 
an assay for L-pipecolate oxidase activity in human liver for the detection of enzyme 
deficiency in hyperpipecolic acidemia patients.66 L-PADH was incubated in 120 111. 
containing 12 mM Tris, 5 mM KC1, pH 8.5, 0.1 mM FAD, 1.0 mM PES, 10 mM 
NaHS03, and 62.5 [iM L-[31-1]-PA (125 p.Ci/limol). The reaction was quenched by the 
addition of 15 p.L of ice cold 0.5 N HC1. The mixture was then applied to a 2 mL Dowex 
50W-X8 column and the column was rinsed with 4.5 mL of ddH2O. The eluant was 
mixed with 10 mL of UniverSol scintillation cocktail and the radioactivity was measured 
by LSC. TLC analysis of the resuspended solid was carried out on aluminum backed 
silica gel in 7:3 EtOH:NH4OH and developed with ninhydrin. 
a-Aminoadipic acid detection: Incubations were carried out with crude 
cell free extracts in a reaction mixture containing 12 mM Tris, 5 mM KC1, 0.1 mM FAD, 
1.0 mM PES, 1.1 mM NAD+, 3.1 mM L-PA, and 0.1 mM L-[31-1]-PA (500 tiCi/i_lmol) at 
pH 8.5. A dual column system was used to separate L-[31-1]-PA and a-PM-AAA.45 
The AG 1X column was stripped with 3 mL of 1 N HOAc and the AG 50W-X8 column 
was stripped with 3 mL of 1 N NH4OH. These eluants were concentrated to dryness 
and resuspended in 150 lit of ddH2O. The resuspended solid was analyzed by paper 
chromatography on Whatman #1 filter paper in 7.7:2.3 EtOH:H20.45  Nitrogen 
containing compounds were visualized with ninhydrin. After development, the paper 
was cut into 1 cm sections, placed in 7 mL vials with 5 mL of scintillation cocktail and 
radioactivity was measured by LSC. 
RESULTS 
L-1-2,3,4,5,6-31-IPPipecolic acid:  D,L42,3,4,5,6-311] -PA was prepared by 
Amersham. The racemic mixture was enzymatically converted to L- [2,3,4,5,6- 3H] -PA 
which was isolated through cation exchange chromatography.45,51  The conversion 
process is shown in Scheme 11.2. D-[3H5] -PA is stereospecifically oxidized to A1 -P2C 
by D-AAO while the L-enantiomer is unaffected.  The 6,1-P2C is then reduced by 
NaBH4 to form D,L43H5]-PA.  The continuous oxidation and reduction cycle 
quantitatively converts D- [3H5] -PA to L- [3H5] -PA. When D-AAO was incubated with 
and aliquot of the converted [3H5]-PA, no 3HOH was observed, suggesting that none of 
the D-enantiomer was present and that the reaction had continued to completeness. After 21 
the cation exchange chromatography and enzymatic conversion, the radiochemical yield of 
500 mCi/mmol L- [3H5] -PA was 79%. 
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Protein Dependence. The dependence of 3HOH production on L-PADH was 
measured by incubating different amounts of protein (final concentrations of 7.8, 5.2 and 
2.6 mg/mL) with the assay mixture containing 12 mM Tris, 5 mM KCI, 0.1 mM FAD, 
1.0 mM PES, and 62.5 pi,M L-[3H] -PA (125 Ki/p.mol). Figure II.1 shows the amount of 
tritiated water produced in the radioassay is dependent on the amount of L-PADH in the 
assay mixture. This indicates that the 3HOH production is enzyme dependent, not a 
result of nonspecific degradation of the tritiated substrate. 
Effect of unlabeled L-PA on radioassay. L-PADH was incubated in the typical 
radioassay mixture with different final concentrations of L-PA. The production of 
tritiated water was monitored by assaying the reactions at 15, 30, 46, and 60 minutes. 
Figure 11.2 illustrates the effect of the addition of unlabeled L-PA to the radioassay 
reaction mixture. The resulting decrease in the amount of 3HOH produced in proportion 
to added unlabeled L-PA indicates the liberated 3HOH is produced from L-[3H5]-PA and 
not from a radiolabeled impurity. 22 
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Figure II.1 Dependence of 3HOH production on L-PADH concentration. 
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Figure 11.2 Effect of unlabeled L-PA on 3HOH production in the radioassay. 23 
pH Dependence. Fractions from a size exclusion column containing L-PADH 
activity were used to study the pH optimum of the L-PA oxidation reaction. Samples 
were incubated in four different buffers at concentrations of 25 mM and various pH 
values as described in Materials and Methods.  The highest L-PADH activity was 
observed at pH 8.5. Both buffers tested at this pH yielded similar results (Figure II.3). 
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Figure 11.3 pH Dependence of L-PADH. 
Purification Procedure: Mature rabbit kidney cortexes were thawed, minced, 
homogenized and subjected to differential centrifugation as described in Materials and 
Methods. The pellet from the centrifugation procedure contained only 5% of the total L­
PADH activity. Consequently, the supernatant was used in all further procedures. As a 
first step in the purification scheme, DEAE-cellulose chromatography was selected. In 
order to determine the optimal conditions for the column, a coarse step gradient with KCI 
was employed to roughly define the elution point of L-PADH. Once this broad elution 24 
profile was determined, the procedure was repeated on a second DEAE-cellulose column 
using narrower steps in the KC1 concentrations (Table II.1). L-PADH elutes from  a 
DEAE-cellulose column between approximately 75 mM and 150 mM KC1 thus a gradient 
stepping from 75 mM to 150 mM KC1 was used in all future DEAE-cellulose 
chromatography procedures. 
Table 11.1 Conditions for DEAE-cellulose chromatography. 
First DEAE column  Second DEAE column 
Conc. KC1  Activity (CPMs)  Conc. KC1  Activity (CPMs) 
0.25 M  2849  0.05 M  0.0 
0.50 M  39  0.10 M  325 
0.75 M  0.0  0.15 M  1358 
1.0 M  0.0  0.20 M  386 
0.25 M  129 
Active fractions from the DEAE-cellulose column were pooled and subjected to 
45% ammonium sulfate precipitation.  Initially, precipitation experiments were carried 
out using the cell free supernatant. From these experiments the optimal ammonium 
sulfate cut was estimated to precipitate between 30% and 50% saturation (Figure 11.4). 
Further studies with the crude material displayed the highest specific activity to 
precipitate between 25% and 45% saturation. When the active fraction from the DEAE-
cellulose column was subjected to a 25% ammonium sulfate precipitation, no significant 
pellet formed after centrifugation, therefore this step was eliminated from the procedure. 
The resuspended pellet from the 45% ammonium sulfate precipitation was 
subjected to size exclusion chromatography on a 2.5 x 110 cm Sephadex® G-150 column 
(Figure 11.5). Active fractions from the Sephadex® G-150 column were combined and 
brought to 1 M ammonium sulfate concentration for further purification by hydrophobic 
interaction chromatography (HIC). Several different HIC supports were investigated and 
the greatest degree of purification with the highest recovery of L-PADH activity  was 
obtained using a butyl Sepharose® resin (Figure 11.6). 25 
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Figure 11.4 Ammonium sulfate precipitation of L-PADH activity. The  open columns 
represent the amount of activity found in the pellet at the corresponding percent 
ammonium sulfate. The filled columns represent the activity in the supernatants. 
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Figure 11.5 Profile of elution volume versus absorbance at 280 nm for Sephadex® G-150 
size exclusion column. The specific activity of L-PADH is superimposed. 26 
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Figure 11.6 Purification of L-PADH on butyl Sepharose® column. The UV absorbance is 
superimposed on the ammonium sulfate gradient. The active enzyme eluted in the 0.5 M 
ammonium sulfate fraction. 
Fractions from the HIC column containing L-PADH activity were pooled and 
concentrated using an Amicon Centriprep 10 centrifugal concentrator. The retentate was 
transferred to a dialysis cartridge (10 kDa molecular weight cutoff) and dialyzed versus 
low salt buffer. 
The final purification step involved anion exchange chromatography on a DEAE 
Fast Flow column. A linear gradient from 10 mM KC1 to 200 mM KC1 was applied over 
50 minutes. Because L-PADH eluted from a previous DEAE column at approximately 
100 mM KC1, fractions near 100 mM KC1 on the DEAE Fast Flow column were initially 
assayed for L-PADH activity. The resulting chromatogram is shown in Figure 11.7. 27 
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Figure 11.7 Elution profile of L-PADH activity from a DEAE Fast Flow column. The 
activity is superimposed over the linear gradient from 10 mM KC1 to 200 mM KC1. 
The active fractions from the DEAE Fast Flow column were pooled and concentrated. 
This procedure resulted in a 300 fold purification of L-PADH with  a final specific 
activity of approximately 400 nmolmg-lhrl. A summary of the L-PADH purification 
is shown in Table 11.2. 
Table 11.2 Partial purification of L-pipecolic acid dehydrogenase from 100 g of rabbit 
kidney cortexes. 
Fraction  Protein 
(mg) 
Total Activity 
(nmol 3HOHhr-1) 
Specific Activity 
(nmol 3HOHmg-lhr-1) 
Purif. 
(fold) 
% Rec. 
cell free  5440  7400  1.4 
DEAE  996  7400  7.6  5.6  100 
AS ppt  227  3341  14.7  10.8  45.1 
G150  20.5  2688  131  96.4  36.3 
Butyl  2.2  547  249  183  7.4 
Dialysate  1.7  349  206  151  4.7 
DEAF FF  0.3  119  396  291  1.6 28 
Fractions from the individual steps in the partial purification of L-PADH were 
analyzed by SDS-PAGE (Figure 11.8). Protein bands at approximately 65, 41, 26 and 15 
kDa continued to appear upon further attempts at purification. From the gel shown in 
Figure 11.6 the most likely L-PADH candidate appears to be one of the bands at 
approximately 41 kDa which were enriched through the purification scheme. However, 
with the data on hand the other proteins at 15, 26, 65 kDa and the higher molecular 
weight bands cannot be discounted. 
Other chromatographic techniques:  Several other chromatographic techniques 
were investigated for use in the purification of the rabbit dehydrogenase. Most of these 
techniques provided little or no increase in specific activity of the enzyme. 
CM-cellulose cation exchange chromatography was studied on a small scale at 
several pH values for the ability to bind L-PADH. CM-cellulose was slurried in 0.5 mL 
of buffer at various pH values between 6.5 and 8.5. Cell free extract (0.2 mL) was added 
to the slurry and gently rocked at 4 °C. Cell free extract without CM-cellulose was also 
rocked at 4 °C and served as a control.  The slurry was centrifuged and the buffer 
decanted and assayed for L-PADH activity (Table 11.3). 
Table 11.3 The effect of pH on binding of L-PADH to CM-cellulose resin. 
10 mM Buffer (pH)  Activity (CPMs) in supernatant 
control (pH = 7.5)  549 
PIPES (pH = 6.5)  322 
HEPES (pH = 7.0)  274 
HEPES (pH = 7.5)  457 
Tris (pH = 8.0)  575 
Tris (pH = 8.5)  748 
It appeared that much of the activity was found in the supernatant at all pH 
values. The difference in apparent activities is probably due to the pH of the buffers; L­
PADH is most active at pH 8.5. However these experiments were performed on a very 
small scale and therefore a larger scale experiment was tried. A 5 mL CM-cellulose 
column was equilibrated in 50 mM BisTris, 10 mM KCI, pH 6.8. When a sample 
containing L-PADH was chromatographed on the column the activity was found only in 
the unretained fractions with no increase in specific activity. MW (kDa) 
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45.0 
31.0 
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Figure 11.7 Silver stained 12.5% SDS-polyacrylamide gel of the L-PADH purification. Lane 1) molecular weight standards, 2) cell free 
extract, 3) DEAE-cellulose, 4) 45% ammonium sulfate precipitate, 5) Sephadex G-150, 6) butyl Sepharose, 7) dialysate, 8) DEAE fast 
flow, 9) molecular weight standards.  t.) 30 
Hydrophobic interaction chromatography using a phenyl Sepharose column was 
used in the purification of the primate oxidase, therefore this method was investigated for 
purification of the rabbit dehydrogenase. Initially the column appeared to provide some 
purification of the enzyme when loaded in a buffer containing 25% ammonium sulfate and 
then eluted in 20% propylene glycol. However, these results were not reproducible. 
Further attempts to purify L-PADH with a phenyl column demonstrated that the 
enzyme bound, but would not elute even when the column was washed with 50% 
propylene glycol followed by 1 M KC1 buffer. 
Several other hydrophobic interaction chromatography medias were investigated 
including butyl, octyl, ether, and methoxy resins. The methoxy and octyl columns were 
not successful in binding the enzyme or increasing the specific activity of L-PADH. The 
dehydrogenase did bind to the ether column, but little activity was recovered. The resin 
to which the hydrophobic functional groups were attached appeared to make a difference 
in the binding of the enzyme. Several supports including, Sepharose® and agarose from 
Pharmacia, Toyo-pearl® from TosoHaas, and Macro-Prep® a ceramic support from 
BioRad were tried. In all of the HIC studies, the protein was loaded in 1 M ammonium 
sulfate, 50 mM HEPES, pH 7.4, and gradients were run with decreasing concentrations of 
salt.  If no activity was found after reaching 0 M ammonium sulfate, dilute solutions of 
propylene glycol or high concentrations of KC1 were used to elute any remaining protein 
off the column. The butyl Sepharose® resin gave the best recovery of activity (20%) 
with the highest specific activity (250 nmolmg-1hr-1). 
Immobilized metal affinity chromatography was investigated using an 
imidodiacetic acid resin. The resin was charged with either copper, nickel, or zinc. The 
protein was loaded in low KC1 buffers and eluted with increasing concentrations of 
imidazole. L-PADH bound to the column regardless of which metal ion was used. 
Copper was selected as the immobilized metal in these studies because recovery of L­
PADH activity was greatest using copper and L-PADH eluted at lower concentrations of 
imidazole than when zinc or nickel were used.  Very low activity was found in the 
imidazole fractions eluted from the copper column.  It was later determined that 
imidazole, at concentrations as low as 25 mM, inhibited the activity of the 
dehydrogenase. Dialysis to remove the imidazole did not lead to increased recovery of 
activity. The enzyme activity was not recovered when high salt buffers were used to 
elute the protein. No L-PADH activity was detected in the 0.1 M EDTA solution used 
to remove the metal ions from the resin. 
Three gel filtration chromatography resins were examined; Sephadex® G-150, G­
100, and G-75. The column dimensions for each were 2.5 x 110 cm and the columns were 31 
equilibrated in 250 mM KC1, 50 mM potassium phosphate, pH 7.4. The highest specific 
activity recovered was associated with the Sephadex® G-150 column. An increase of 
approximately nine fold in purification was achieved with this step. 
Because L-pipecolic acid dehydrogenase appears to utilize a non-covalent flavin in 
the oxidation of L-PA, purification on a FAD agarose affinity column was attempted. L­
PADH was loaded onto a 0.8 mL column in 10 mM KC1, 50 mM HEPES, pH 7.4. Two 
elution buffers were used, one contained 1 M KC1 and the other contained 5 mM FAD. 
Under both conditions L-PADH activity was only seen in the unretained material. 
Neither column resulted in an increase in the purity of the enzyme. 
Attempts were also made to purify the enzyme using strong anion and cation 
exchange resins. These included types Mono S and Mono Q from BioRad. The Mono S 
is a strong cation exchange column that contains an alkyl sulfonate functional group. The 
Mono Q is a strong anion exchange column that utilizes a quaternary amine. Both 
columns were equilibrated and loaded in low salt buffers and were run on low pressure 
and high pressure chromatography systems. The L-PADH activity in each case was 
found in the unretained portion, and no other significant UV absorbing peaks appeared 
even after washing with 1 M KCl buffer. 
Purification of L-PADH on a Macro-Prep® hydroxylapatite column was also 
tried.  Hydroxylapatite can be used to separate acidic, basic, and neutral proteins. L­
PADH was loaded according to manufacturers directions onto a 1 mL column in 0.1 M 
potassium phosphate, pH 5.8, and washed with the same buffer. A step gradient of 0.2, 
0.3, and 0.4 M potassium phosphate, pH 5.8, followed.  The activity for the 
dehydrogenase and the only UV absorbance detected was in the unretained fractions and 
no increase of specific activity was found as a result of this purification step. 
Dye affinity chromatography was attempted to purify the rabbit dehydrogenase 
further and possibly isolate the enzyme involved in the oxidation of a-ASA to a-AAA. 
The second enzyme involved in the degradation of L-PA catalyzes the oxidation of a-
ASA to a-AAA and has been shown to be NAD+ dependent.45 Affi -Gel Blue-Gel® dye 
affinity resin from BioRad was used with linear and step gradients of increasing KC1 
concentrations. The dual column ion exchange assay was used to analyze the column 
fractions for activity. No significant amounts of 3HOH or a-[31-1]-AAA were detected. 
In addition to various soft gel techniques, HPLC methods were also employed to 
purify L-PADH. Two POROS® resins from PerSeptive Biosystems were tried using a 
Beckman BioSys 510 chromatography system. A cell free extract that had been subjected 
to ammonium sulfate precipitation was applied to a weak anion exchange column 
( POROS® PI) equilibrated in 10 mM KCI, 50 mM HEPES, pH 7.4. A linear gradient 32 
from 10 mM to 1 M KCl in 50 mM HEPES, pH 7.4, was used to elute bound protein. 
No increase in purification was obtained when the specific activity of the active 
POROS® fractions were compared to that from the DEAE-cellulose step in the standard 
protocol. Active L-PADH material from a Sephadex® G-150 column was applied to the 
weak anion exchange column and run under the same conditions. No significant increase 
in purification was observed. Chromatography on a phenyl ( POROS® HP2) column was 
also performed. After the protein was loaded in 1 M ammonium sulfate, 50 mM HEPES, 
pH 7.4, a linear gradient from 1 M to 0 M ammonium sulfate applied. Very little activity 
was recovered and there was no increase in purification. 
Mitochondria isolation: A mitochondria isolation was attempted in order to 
reduce total protein levels in the crude extracts.  Frozen rabbit kidney cortexes were 
homogenized and centrifuged according to the procedure described in Material and 
Methods. Only very low glutamate dehydrogenase activity was detected in the soluble 
kidney mitochondria fraction when compared to the standard. No activity was observed 
in the mitochondrial pellets. Commercially available rabbit kidney cortexes are dipped in 
liquid nitrogen and shipped in dry ice for preservation. These results suggest the thawed 
tissue contained mitochondria that had already lysed.  Effective isolation of the 
mitochondria would therefore not be possible without fresh tissue. 
Native molecular weight estimation. Two calibrated size exclusion columns 
(Sephadex® G-100 and G-75) were used to estimate the native molecular weight of L­
PADH. Protein standards of known molecular weight were applied to the columns and 
the Ve was measured for each. A standard curve was produced by plotting the log of the 
molecular weight versus the Ve/Vo ratio. L-PADH was then chromatographed on both 
columns and the Ve was measured at the point where the specific activity was highest 
(Figure 11.9). The native molecular weight of L-PADH was estimated from the standard 
curve. The highest specific activity of L-PADH eluted at a Ve/Vo = 1.42 on the G-100 
column, providing a molecular weight estimate of 45 kDa. The calculated L-PADH VeNo 
from the calibrated G-75 column was 1.24, corresponding to a molecular weight of 52 
kDa. L-PADH native molecular weight was estimated at approximately 49 kDa. 
Native gel electrophoresis. Native gel electrophoresis was explored in order to 
identify which of the protein band(s) identified using SDS-PAGE might be associated 
with L-PADH activity. If a substantial amount of activity could be recovered from native 
gel electrophoresis then this procedure could be attempted on a preparative scale. Native 
gel electrophoresis was first tried using slab gels in order to conserve materials and 
enzyme as well as to determine whether activity could be recovered. The manual for 33 
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Figure 119 Native molecular weight determination of L-PADH by calibrated gel filtration 
chromatography. 
preparative native gel electrophoresis suggested that the first attempt at native gel 
electrophoresis follow the Ornstein-Davis system.55,56,67 This discontinuous system 
consisted of a stacking gel and sample loading buffer at pH 6.8, and resolving gel and tank 
buffer at pH 8.8 (Table 11.4). 
The gels were divided into 1 cm slices and each slice analyzed for L-PADH 
activity using the radioassay. The first conditions tried were a 10 % resolving gel with a 
4% stacking gel electrophoresed for 14 hours. Low amounts of activity were recovered 
from the initial native gel, therefore several experiments were conducted in order to 
optimize the electrophoretic conditions. Some of these conditions included altering the 
percent acrylamide in the resolving gel, or eliminating the stacking gel. A 6% gel was 
utilized to obtain further migration of the protein, however the enzyme mobility was 
unchanged for electrophoresis times up to 12 hours. In almost every case a diffuse band 34 
of protein was seen at the top of the native gel. These results suggested that a different 
buffer system should be tried. 
Table II. 4 Conditions of native gel electrophoresis using the Ornstein-Davis buffer 
system. 
Gel composition  run time (hr)  Rf of activity 
4% stacker, 10% gel  14  0.4 
4% stacker, 6 % gel  12  0.4 
6% gel only  12  0.4 
10% gel only  19  0.4 
The Jovin system, a discontinuous system, consists of cathode buffer at pH 7.25, 
anode buffer at pI1 5.9, and both gel and sample buffers at pH 6.61.57 The protein 
migration increased using this buffer system and longer electrophoresis times (Table II.5). 
Table 11.5 Conditions and results using the Jovin native gel system. 
Gel composition  run time (hr)  Rf of activity  % recovery 
4% stacker, 10% gel  14  0.2  19.7 
4% stacker, 6 % gel  8  0.2  20.8 
4% stacker, 6 % gel  24  0.7  15.0 
SDS-PAGE analysis of the slices containing activity from the 6% native gel run 
for 24 hours are shown in Figure 11.8. SDS-PAGE displayed an enriched band at 26 kDa 
and bands near 50 kDa, but the bands at 41 kDa and 15 kDa on the SDS-polyacrylamide 
gel from the purification procedure were not seen. These results suggested that L-PADH 
may be a monomer of approximately 50 kDa, or a homodimer consisting of 26 kDa 
monomers. 35 
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Figure II.10 L-PADH activity and corresponding SDS-polyacrylamide gel of gel slices 
from a 6% native gel run in the Jovin buffer system. 36 
Preparative native gel electrophoresis was carried out using a BioRad model 491 
Prep Cell®.  Initial studies with the Jovin buffer system resulted in no recovery of 
activity and an apparent focusing of the protein near the top of the gel. Because the 
protein appeared to focus on the preparative gel, native electrophoresis on slab gels were 
reinvestigated using a different buffer system. The McLellan system is a continuous 
buffer system in which the gel buffer and tank buffer are the same.58 Of the three native 
gel systems tried, the McLellan system gave the highest percent recovery with the 
furthest migration of L-PADH activity (Table 11.6). 
Table H.6 Conditions and results using the McLellan native gel system. 
Gel composition  run time (hr)  Rf of activity  % recovery 
4% stacker, 6% gel  12  0.3  35.0 
4% stacker, 6% gel  20  0.8  19.2 
6% gel, no stacker  12  0.6  23.5 
4% stacker, 10% gel  24  0.6  18.6 
Preparative native gel electrophoresis was attempted again using the McLellan 
buffer system and a 6% acrylamide native resolving gel (5 cm) with a 4% stacking gel (1 
cm). Twenty milligrams of protein from an active HIC fraction was applied to the gel. 
Electrophoresis was carried out at 10 watts for 7 hours and L-PADH was detected by the 
radioassay (Figure II.11). Two peaks were detected by UV absorbance (280 nm). The 
first peak was due to the sample loading dye and the second peak contained protein. L­
PADH activity was detected between the two UV peaks, however there was no increase 
in the specific activity.  This lack of increase in specific activity was likely due to the 
denaturing of active protein during electrophoresis. SDS-PAGE analysis of these protein 
fractions revealed the presence of the usual four protein bands (ca. 65, 41, 26, and 15 
kDa). 
Western blot analysis.  Further attempts to identify L-PADH on a SDS­
polyacrylamide gel utilized Western blot analysis.  Polyclonal rabbit antibodies were 
generated towards the purified monkey L-PO and provided as a gift from Prof. Stephanie 
J. Mihalik (Johns Hopkins University).47  Partially purified rabbit dehydrogenase 
samples were electrophoresed on a 12.5% SDS-polyacrylamide gel and electroblotted 
onto a nitrocellulose membrane. The membrane was incubated with the rabbit anti­37 
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Figure II.11  Elution profile of L -PLDH activity from a preparative electrophoresis 
experiment. The first UV active peak is the sample loading buffer with dye. The second 
UV absorbing peak is protein eluted from the native gel. L-PADH activity was detected 
shortly after the loading dye eluted. 
monkey antisera and goat anti-rabbit IgG conjugated with alkaline phosphatase. No 
protein bands were visualized upon development as described in Material and Methods. 
The L-PADH samples did not cross-react with the rabbit anti-monkey antisera. Active 
L-PADH samples from a 6% native gel were also subjected to SDS-PAGE and Western 
blot analysis, but the rabbit anti-monkey antisera did not cross-react with these L-PADH 
samples either. 
Immunoprecipitation. The Western blot analysis of L-PADH may not have been 
successful because of the small amount of protein applied to the gels.  Therefore, an 
immunoprecipitation protocol was conducted on a larger protein sample. The rabbit anti-
monkey antisera (1:170) was incubated with partially purified L-PADH samples and 
purified L-PO as a control.  Protein A Sepharose® was added and the mixtures were 
centrifuged. The supernatants were assayed for activity using the radioassay. No loss of 
activity was observed in the L-PADH samples, but the L-PO control resulted in an 80% 
decrease of activity.  Both the supernatants and the pellets were analyzed by SDS­
PAGE. Only the rabbit anti-monkey antisera band at 50 kDa was observed in lanes 38 
containing the pellet fractions. There were no disappearance of bands in the L-PADH 
supernatants, but the L-PO supernatant fraction did not display the 46 kDa band of the 
purified L-PO. It was possible that the L-PO 46 kDa band was hidden under the large 
rabbit anti-monkey antisera band at 50 kDa in the pellet fraction. Thus, L-PADH does 
not cross-react with the rabbit anti-monkey antisera. 
Native gel activity stain. This is a modification of an experiment originally used to 
identify the protein band on a native gel that contained sarcosine dehydrogenase.6° 
Sarcosine dehydrogenase possesses a covalent flavin that is reduced during the oxidation 
of sarcosine.68 Phenazine methosulfate a substitute electron acceptor, reoxidizes the 
covalent flavin on the enzyme. Phenazine methosulfate is reoxidized by p-nitro blue 
tetrazolium chloride which, when reduced, precipitates forming a blue band in the gel. 
Sections of a 6% native gel containing L-PADH activity were incubated in the assay 
mixture (0.1 M potassium phosphate, pH 7.4, 0.1 M L-PA, 0.04 mM FAD, 0.2 mM 
PES, and 0.5 mM NBT) overnight. p-Nitro blue tetrazolium chloride did not precipitate 
anywhere in the gel. 
Isoelectric point. In order to determine the pI of L-PADH in a non-homogeneous 
sample, preparative isoelectric focusing experiments were performed using a BioRad 
Rotofor Cell®.  Several different sets of conditions were attempted using broad range 
ampholytes (pH 3-10), (Table 11.7). 
Table 11.7 Conditions and results of preparative isoelectrofocusing of L-PADH. 
Cell (mL)  wattage  run time (hr)  active fraction  pH  comments 
20  12  5  none 
60  15  6  fraction 7  5.7  precipitation 
20  12  2  fraction 6  5.5  precipitation 
20  12  2  none  5% glycerol 
20  10  3  none  15% glycerol 
L-PADH activity was only detected in fractions that contained protein that 
precipitated during focusing.  The pH of these fractions were pH 5.5 and 5.7.  An 
approximation of the pI of L-PADH was estimated to be 5.6 from these experiments. 
Glycerol was added to the protein sample in order to maintain the solubility of the 39 
protein. Glycerol prevented precipitation, but no activity was detected in any fraction. 
Inactive fractions that had been solubilized with glycerol were concentrated and 
resuspended in pH 8.5 buffer. The buffer exchanged fractions were assayed for activity, 
but none was recovered. SDS-PAGE analysis of these inactive fractions revealed that 
protein was present in fractions 6,  7, 8 and 9, corresponding to pH values of 
approximately 5.0 to 6.5.  These experiments suggest that the pI of L-PADH is 
approximately 5.6. 
Kinetic parameters. A dye-linked assay using DCPIP was used to determine the 
kinetic parameters of L-PADH with L-PA as substrate.61 During the oxidation of L-PA, 
two electrons are transferred to FAD. FAD is reoxidized by PES which is then 
reoxidized by DCPIP. Oxidized DCPIP is dark blue in color and when reduced becomes 
colorless. The progress of the reaction can be followed by a decrease in absorbance at 600 
nm (Scheme II.3). 
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Using the DCPIP spectrophotornetric assay, the oxidation of L-PA by L-PADH 
was shown to follow Michaelis-Menten kinetics (Figure II. 12). The assay mixtures were 
kept at 37 °C and contained 12 mM Tris, pH 8.5, 5 mM KCI, 0.1 mM DCPIP, 1 mM 
KCN, 0.07 mM FAD, 0.7 mM PES, and 25 1.1L of partially purified L-PADH in a total 
volume of 0.5 mL. The reactions were initiated with L-PA at concentrations ranging from 
. 0.1 mM to 5 mM  The KmaPP of L-PADH was estimated to be 0.88 mM with a Vmax of 
0.02 limolmg-1min-1. 
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Figure 11.12 Non-linear regression analysis of the kinetic study of L-PADH. L-PA 
concentrations ranged from 0.1 mM to 5 mM. Inset: Lineweaver-Burke plot of the 
results. 
Stereochernical course of oxidation of L-PA by L-PADH. The stereochemical 
course of the oxidation of L-PA by L-PADH was investigated using L-PA 
stereospecifically deuterated at C-6.62 L- [6R- 2H] -PA and Lt6S-21-1]-PA were incubated 
with L-PADH at 1 mM final concentrations and the rate of oxidation was measured using 41 
the DCPIP assay. Unlabeled L-PA was used as a control. The initial reaction rates were 
obtained from the linear portion of the progress curves (Figure 11.13). 
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Figure 11.13 Time course for the oxidation of L- [6R- 2H] -PA and L-[6S-2H]-PA by L­
PADH. 
A rate of 0.020 nmol productmg-1sec-1 was determined for L-PA. The observed rates 
for L- [6R- 2H] -PA and L46S-211J-PA were 0.005 and 0.014 nmol productmg-sec-1, 
respectively. These data suggest that a primary isotope effect is observed with L-[6R­
21-1]-PA as the substrate with a kH/kD of 4.1. Turnover of L- [6S- 2H] -PA displayed a 
significantly lower isotope effect, kFuticD=1.4.  These data suggest that the pro-6R 
hydrogen of L-PA is abstracted by L-PADH during the oxidation process and that the 
hydrogen abstraction is at least partially rate limiting. 42 
Turnover product,  The isolation of the turnover product of L-PADH was 
important for many reasons, primarily to compare L-PADH with L-PO.  The first 
chemically stable product of L-PA degradation has been shown to be a-AAA in both the 
monkey and the rabbit.45 The immediate product of the enzymatic oxidation of L-PA in 
the rabbit has not been identified, but a-ASA has been shown to be the turnover product 
of monkey L-PO.66 The isolation of the L-PADH turnover product would also facilitate 
the investigation of the mechanism of oxidation by L-PADH using alternate substrates, 
thus providing useful comparative information between L-PO and L-PADH. 
Phenylisothiocyanate and 9-fluorenylmethyl chloroformate were used in order to 
derivatize the turnover product of L-PADH. These derivatives offer high sensitivity and 
allow the separation of various amino acids by HPLC. Other procedures were tried in 
order to determine the turnover product of L-PADH. These included formation of a 
bisulfite adduct, NaB3H4 treatment and a-AAA detection. The following describes the 
results from these experiments. 
Phenylisothiocvanate (PITC): PITC reacts with amino acids and produces 
derivatives that can be separated by HPLC. L-PADH was incubated overnight with an 
excess of L-PA. The turnover product of L-PO has been characterized as a-ASA and 
therefore L-PO was also incubated overnight under these conditions and used as a control 
to establish the retention time of the derivatized a-ASA.66 The assay mixtures were 
derivatized with PITC and analyzed by reverse phase (C18) HPLC. The L-PO sample 
produced two peaks: a peak that contained the PITC derivative of L-PA and a peak with 
a shorter retention time. Because a-ASA is expected to be more polar than L-PA, it was 
believed that this peak was the PITC derivative of a-ASA. This was confirmed when L­
PO was incubated with L- [3H5] -PA and both peaks from HPLC analysis contained 
radioactivity.  L-PADH samples produced only the peak that contained the PITC 
derivative of L-PA. When L-PADH was incubated with L- [3H5] -PA, treated with PITC, 
and analyzed by HPLC, the only radioactivity detected was in the L-PA peak.  It was 
concluded that PITC did not react with the turnover product of L-PADH. 
9-Fluorenylmethyl  chloroformate (FMOC): FMOC reacts with 
secondary amino acids to form stable, fluorescent derivatives. L-PADH was incubated 
with FAD, PES, and an excess of L-PA for 0, 0.5, 1, 2, 4, and 8 hours. FMOC was added 
to the enzyme mixtures and the solutions were extracted with ether. The aqueous layer 
was concentrated to dryness and the solid was dissolved and analyzed by HPLC using a 
reverse phase (C18) column. Several peaks appeared from HPLC analysis. None of the 
peaks areas increased with time and no new peaks were evident even after 8 hours. It was 
concluded that FMOC did not derivatize the L-PADH turnover product. 43 
Reduction with tritiated sodium borohydride:  To investigate the 
possibility of trapping Al-P6C and showing that it is an intermediate in the oxidation of 
L-PA by L-PADH, NaB3H4 was used to reduce A 1-P6C back to L-PA containing a 
tritium label.65 A diagram for the reduction of A1 -P6C with sodium boro[3H]hydride is 
shown in Scheme II.4. 
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L-PADH was incubated with excess L-PA and then NaB3H4 was added to the 
mixture. The reaction was quenched with HC1 and the mixture was applied to a Dowex 
50 column. L-PA was eluted from the column using 1 M NH4OH and concentrated to 
dryness.  The solid was resuspended and subjected to TLC analysis in 7:3 
EtOH:NH4OH. Nitrogen compounds were detected with ninhydrin. The TLC plates 
were cut into sections and the silica gel was scraped off and assayed for radioactivity. 
Although a ninhydrin positive spot appeared with the same Rf of L-PA (0.88), no 
radioactivity was associated with it. 
Formation of a-ASA/Bi sulfite adduct: This procedure was developed as 
an assay for L-PO activity in the human liver.66 Sodium bisulfite reacts with aldehydes 
to produce a bisulfite adduct. With L-PO, sodium bisulfite reacts with a-ASA to form a 
bisulfite adduct with a net negative charge and allows separation form L-PA (Scheme 
11.5).  In the standard enzyme radioassay a-ASA binds to the Dowex 50W-X8 cation 
exchange resin. The bisulfite adduct of a-ASA is negatively charged and will not be 
retained by the Dowex 50W-X8 column. The bisulfite adduct will therefore pass through 
the cation exchange resin. 44 
H  02C,,  H 
H2O  NaHS03 +)4( L-PADH 
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Scheme 11.5. 
L-PADH was incubated with FAD, PES, L- [3H5] -PA and sodium bisulfite. The 
enzyme mixture was applied to a 2 mL Dowex 50W-X8 cation exchange column and the 
column was washed with 4.5 mL of ddH2O. The water fraction was evaporated to 
dryness and resuspended, but no radioactivity was detected in the resuspended solid. 
The resuspended solid was analyzed by TLC in 7:3 EtOH:NH4OH. The resuspended 
solid did not contain a ninhydrin positive spot. These results suggest that a-ASA is not 
a released product of L-PADH 
a-Aminoadipic acid detection: Crude rabbit kidney cortex homogenate 
was incubated at 37 °C for one hour with FAD, PES, L-[3H5] -PA, and NAD+. The 
NAD+ cofactor is required for a-ASA dehydrogenase, which converts a-ASA to a-
AAA. The enzyme mixtures were applied to a dual column system consisting of AG 1X 
anion exchange and Dowex 50W-X8 cation exchange resins. The columns were washed 
with ddH2O, and the AG lx anion exchange and Dowex 50W-X8 cation exchange resins 
were stripped with HOAc and NH4OH, respectively. The ddH2O wash and the HOAc 
and NH4OH fractions were concentrated to dryness and dissolved in ddH2O. These 
fractions were analyzed by paper chromatography on Whatman #1 filter paper in 7:3 
EtOH:H20. A smeared ninhydrin positive spot appeared for both the AG lx and 
Dowex 50W-X8 fractions. The paper was cut into sections and assayed for radioactivity. 
The sections that had the greatest activity were used to measure the Rf values. The Rf 
values from monkey preparations were determined previously and reported as 0.91 for L­
PA and 0.61 for a-AAA.45 The Rf values of the rabbit sample from the Dowex 50W-X8 
column (L-PA) was 0.9 and that from the AG-1X column (a-AAA) was 0.7.  This 
confirms that the rabbit kidney extracts produce a-AAA, however an intermediate 
between L-PA and a-AAA has not been identified and isolated. 45 
DISCUSSION 
L-Pipecolic acid dehydrogenase has been partially purified 300 fold from rabbit 
kidney cortex. L-PADH has a molecular weight of approximately 50 kDa and may be a 
monomer or a homodimer consisting of 26 kDa subunits. This protein has an estimated 
pI of 5.6 and a pH optimum of 8.5. The Km of L-PADH for L-PA is 0.88 mM with an 
observed V  of 0.02 .tniolmin-img-1. 
The purification procedure utilized herein has identified some of the properties of 
L-PADH. The enzyme appears to be an acidic protein with an estimated pI of 5.6. The 
ability of L-PADH to bind a DEAE resin at pH 7.4 coupled with the inability to bind to a 
CM resin at pH 6.5 further suggests that L-PADH is an acidic protein. 
Although L-PADH is a soluble enzyme, it exhibits some hydrophobic character 
based on its interaction with HIC resins. L-PADH binds irreversibly to a phenyl­
substituted resin, but can be eluted from a butyl-substituted resin which is weaker in 
hydrophobicity. 
Other techniques that provided an increase in the purification of L-PADH with 
substantial recovery of activity were ammonium sulfate precipitation and size exclusion 
chromatography. L-PADH precipitated with ammonium sulfate over a broad range of 25 
to 45% saturation, and resulted in a two fold increase in specific activity. Size exclusion 
chromatography provided the greatest Increase in purification, nine fold, of any single 
step. Of the three size exclusion resins tried, the Sephadex® G-150 gave the greatest 
increase in purification of L-PADH. 
Native gel electrophoresis which separates proteins by mass and charge, two 
characteristics that together would appear to make a protein unique, did not facilitate the 
purification of L-PADH.  Multiple protein bands were present in the SDS-PAGE 
analyses of native gel fractions containing L-PADH activity. 
Western blot analysis of L-PADH with rabbit anti-monkey antisera was 
investigated as a means to identify the L-PADH band on a SDS-polyacrylamide gel. The 
rabbit anti-monkey antisera did not cross-react with any protein in active L-PADH 
fractions or native gel sections. Immunoprecipitation experiments using the rabbit anti-
monkey antisera did not result in a loss of soluble L-PADH activity. 
Several experiments were carried out in order to elucidate the turnover product of 
L-PADH. It has been suggested that the oxidation of L-PA produces Al-P6C which is in 
equilibrium with its open chain form a-ASA.23 Both PITC and FMOC react with amino 
acids and these compounds were used to derivatize A 1-P6C and/or a-ASA. No 
derivatization of A 1-P6C or a-ASA was observed in L-PADH samples when PITC and 46 
FMOC were used. Another means by which A 1-P6C can be detected as the turnover 
product of L-PADH utilized tritiated sodium borohydride to reduce A 1-P6C back to L­
PA containing a tritium label. No detection of radioactivity was observed in the recovered 
L-PA. Sodium bisulfite was added in order to produce a bisulfite adduct of a-ASA, 
however no reaction was detected.  When crude rabbit kidney homogenates were 
incubated with FAD and NAD±, a-AAA was detected.  This suggests that the final 
product in the oxidation of L-PA in rabbit preparations is a-AAA. The inability to 
isolate or detect the intermediate between L-PA and a-AAA suggests that the turnover 
product of L-PADH is either not released or is produced in amounts below the level of 
detection. 
It is important to compare mitochondrial L-PADH with other amino acid 
dehydrogenases, specifically proline dehydrogenase. Proline dehydrogenase isolated from 
Escherichia coil and Salmonella typhimurium are both multifunctional enzymes that 
catalyze the oxidation of L-proline to L-glutamate via A1-pyrroline-5-carboxylate.69,7° In 
the rat L-proline dehydrogenase only catalyzes the oxidation of L-proline to A 1­
pyrroline-5-carboxylate.71 From our data it is difficult to conclude whether or not L­
PADH is a multifunctional enzyme, although the only turnover product that has been 
identified is a-AAA. However, L-PADH has a native molecular weight of only 50 kDa 
and the multifunctional proline dehydrogenases mentioned above have native molecular 
weights of 260 kDA. Although proline dehydrogenase has been shown to oxidize L-PA 
analogs, L-proline did not significantly inhibit the activity of L-PADH suggesting that the 
L-PADH activity is specific for L-PA.45,7° 
A comparison of the enzymes involved in mammalian pipecolate oxidation reveals 
several fascinating differences and similarities; particularly properties such as subcellular 
location, mode of cofactor association and reoxidation, and kinetic parameters. A 
comparison of the primate oxidase and rabbit dehydrogenase is summarized in Table II.8. 
Rabbit mitochondrial L-PADH is a soluble enzyme of approximately 50 kDa, while L-PO 
is a monomer at 46 kDa and is a membrane-associated protein located in the peroxisomes 
of primates.47 L-PO has a covalently bound flavin cofactor and molecular oxygen serves 
as the electron acceptor in the catalyzed oxidation of L-PA, the formation of H202 being 
the result.47 L-PADH also utilizes a flavin cofactor, but it requires the addition of an 
electron acceptor such as phenazine ethosulfate in order to reoxidize the flavin back to the 
catalytically active form. It has been suggested that L-PADH eventually shuttles the 
electrons from L-PA through the electron transport chain.45 47 
Table 11.8 Comparison of L-pipecolic acid oxidase and L-pipecolic acid dehydrogenase. 
Characteristic  L-PO  L-PADH 
species  primates  lower mammals 
location  peroxisomes  mitochondria 
soluble vs. insoluble  membrane associated  soluble 
cofactors  covalently bound FAD  activity stimulated by addition 
of FAD 
H202 is produced  requires addition of an electron 
acceptor 
Km (L-PA)  3.7 mM  0.88 mM 
Vmax (L-PA)  2.1 jimolmin-1mg-1  0.02 pmolmin-1mg-1 
6-H abstraction  pro 6R  pro 6R 
Molecular Weight  46 lcDa  50 kDa 
pH Optimum  8.5  8.5 
pI  8.9  estimated at 5.6 
The Km of L-PO for L-PA is four fold higher than that of L-PADH, suggesting 
that L-PO has a lower affinity for L-PA as a substrate. The maximum velocity of L-PO 
is 100 fold greater than the dehydrogenase, but it should be noted that the value 
determined for the dehydrogenase is from a non-homogenous enzyme. Both enzymes 
have a pH optimum of 8.5 and abstract the pro-6R hydrogen from L-PA.72 While the pI 
of the oxidase is 8.9 indicating that it is a basic protein, the pI of the dehydrogenase is 
estimated to have an acidic isoelectric point at pH 5.6. 
When the yeast oxidase and bacterial dehydrogenase are also considered (cf. 
Chapter I), the evolutionary relationship of the enzymes involved in L-PA oxidation is 
quite intriguing. Both the rabbit dehydrogenase and the dehydrogenase from P. putida 
require FAD, however the rabbit enzyme is soluble while the bacterial enzyme is 
membrane bound.32 The oxidase from primates is membrane-associated and possesses a 
covalent FAD, but the yeast oxidase from R. glutinis has been reported as requiring no 
cofactor.4°,41  Ultimately, sequence information at the DNA level will be required to 
establish the convergent or divergent evolution of the enzymes involved in pipecolic acid 
oxidation. 48 
CHAPTER III
 
ALTERNATE SUBSTRATES OF L-PIPECOLIC ACID DEHYDROGENASE
 
INTRODUCTION
 
Early studies by Mihalik and Rhead revealed that primate and rabbit tissue 
preparations containing L-pipecolic acid (L-PA) oxidizing activity were highly specific 
for L-PA as substrate.45 In order to verify that L-PA was not being oxidized by enzymes 
in other pathways with structurally related substrates, it was shown that glutamate, L-
proline and D-alanine had little effect on cell-free studies of L-pipecolate oxidation, thus 
excluding significant contributions to the observed activity by saccharopine 
dehydrogenase, proline dehydrogenase or D-amino acid oxidase. 
The purification of Rhesus liver L-PO allowed more extensive studies on the 
oxidation of alternate substrates to be conducted.47,73 Purified L-PO demonstrated high 
specificity for L-PA when compared with activity towards numerous D- and L-amino 
acids.73 The only compounds other than L-PA that served as substrates for L-PO were 
L-proline and sarcosine, which were oxidized at rates 23% and 10%, respectively, of that 
seen for L-PA.47,73 
In the initial studies describing the subcellular location of rabbit L-PADH in the 
kidney mitochondria, several structural analogs were evaluated for the ability to affect L­
PA oxidation. Piperidine, L-proline, nipecotic acid (piperidine-3-carboxylic acid) and cis-
2,4-piperidine dicarboxylic acid were shown to have a negligible effect on the reaction.45 
Identification of alternate substrates may provide useful information for comparative 
studies of L-PO and L-PADH. Furthermore, analogs of L-PA could also serve as valuable 
probes to study the exact chemical mechanisms catatalyzed by these enzymes. 
A number of L-PA analogs have been synthesized and tested as potential 
inhibitors of and alternate substrates for, L-PO and L-PADH.  Many of these 
compounds were designed as inhibitors of the primate oxidase to serve as potential leads 
to therapeutic agents for treating convulsive disorders and as pharmacological tools to 
study the role of L-PA in the mammalian CNS. The design of these compounds was 
based on a proposed mechanism for flavin-dependent oxidation of L-PA (Scheme 111.1). H 
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This scheme was developed from mechanistic data proposed for other highly-studied 
flavin-dependent amine oxidases such as monoamine oxidase.74,75 Compounds were 
sought which could stabilize or relocate a possible a-amino radical generated during the 
oxidation process. Alternate substrates which can stabilize a radical intermediate may 
function as better substrates and as valuable tools for spectroscopic studies of these 
enzymes.  Stabilization of a highly reactive radical species may also lead to alternate 
decomposition pathways resulting in enzyme inactivation. A delocalized radical may 
result in a reactive species that combines with an active site radical or abstracts a 
hydrogen from the enzyme leading to inactivation. 
MATERIALS AND METHODS 
Materials. All biochemicals and solvents were purchased from Sigma, Fisher and 
VWR. All buffers and solutions were made using double deionized and filtered (0.45 mm) 
water (NANOpure, Barnstead). L-PA (1), L-proline (2), sarcosine (5), 3,4-dehydro-L­
proline (6), and (R)-thiazolidine-4-carboxylic acid (11) were purchased from Sigma. 
Compound 7 (4,5-dehydro-L-pipecolic acid) was prepared by Dr. Mark Zabriskie. The 
nitrogen substituted analogs, N-nitroso-L-pipecolate (3) and N-methyl-L-pipecolate (4), 
were synthesized by Hua Qi. (R,S)-1,3-Oxazane-4-carboxylic acid  (8), (S)­
hexahydropyrimidine-4-carboxylic acid (9), (R,S)-piperazine-2-carboxylic acid (10), (5)­
1,3-thiazane-4-carboxylic acid (12), (2R, 4S)-2-methyl-1,3-thiazane-4-carboxylic acid 
(13a), (2S, 4S)-2-methyl -1,3-thiazane-4-carboxylic acid (13b), (35)-1,4-thiazane-3­
carboxylic acid (14), (35)-1-oxo-1,4-thiazane-3-carboxylic acid (15a), and (35)-1,1-dioxo­
1,4-thiazane-3-carboxylic acid (15b) were gifts from Xi Liang.  Spectrophotometric 
studies were carried out on a Hitachi U2000 spectrophotometer. 
Kinetic studies of L-PADH with L-pipecolic acid analogs. Several L-PA analogs 
were synthesized as potential inhibitors of L-PO.76,77 These compounds were evaluated 
for activity  as  substrates and/or inhibitors of L-PADH using the DCPIP 
spectrophotometric assay described in Chapter II.61 The reaction mixture contained 12 
mM Tris, pH 8.5, 5 mM KCI, 0.1 mM DCPIP (c = 21.5 Lmmol-1cm-1), 1 mM KCN, 
0.07 mM FAD and 0.7 mM PES. A sample of L-PADH (62 pig), partially purified to the 
point of a Sephadex® G-150 size exclusion column, was used in the assays. Controls 
omitting enzyme or substrate analogs were conducted for all compounds. A substantial 
decrease in absorbance was often seen in the controls without L-PADH and this value 51 
was subtracted from the rate of the complete reaction mixture. The Enzyme Kinetics 
software package from Trinity Software was used to analyze the data. 
Time-dependent inactivation. The reaction mixture contained 12 mM Tris, pH 
8.5, 5 mM KC1, 0.1 mM FAD, 1.0 mM PES, 5 mM 4,5-dehydro-L-pipecolate (7), and 
0.45 mg of L-PADH purified to the point of an HIC column in 80 [tI, total volume. A 
control without 4,5-dehydro-L-pipecolate (7) was also analyzed. The reactions incubated 
at room temperature. In order to dilute the inhibitor and assay the enzyme for activity, a 
10 p.L aliquot of the reaction mixture was added to 490 lit of reaction buffer kept at 37 
°C containing 12 mM Tris, pH 8.5, 5 mM KC1, 0.07 mM FAD, 0.7 mM PES, 0.1 mM 
DCPIP, 1 mM KCN, and 5 mM L-PA. The reaction was assayed for activity at 5 
minutes, 20 minutes, 1, 4, 8, and 24 hours. The DCPIP reduction was monitored at 595 
MTh 
RESULTS 
Sixteen analogs of L-PA were tested as inhibitors and substrates of partially 
purified L-PADH. The kinetic data are summarized in Tables III.1, 111.2 and 111.3. The 
ability of L-PADH to oxidize L-Proline (2) and sarcosine (5) was of interest because both 
proline dehydrogenase and sarcosine dehydrogenase will recognize L-PA as a substrate, 
albeit a poor one.78 L-PADH was able to oxidize both of these structural analogs at rates 
approximately 45% of that observed for L-PA (Table III.1), demonstrating an interesting 
reciprocal substrate relationship for these three similar flavin-dependent amine oxidases. 
The effect of substituents on the pipecolate nitrogen was also tested. N-Nitroso-
L-PA (3) served as a poor substrate for L-PADH with an observed turnover rate 20% of 
that seen with pipecolic acid at the same concentration. The N-methylated analog 4 had 
no effect on L-PADH activity and also failed to act as a surrogate substrate (Table 111.1). 
One class of compounds with the potential to increase the stability of a radical 
intermediate are those with an adjacent double bond, allowing for the formation of a 
delocalized allylic radica1.79,80  Both 3,4-dehydro-L-proline (A3,4-L-proline, 6) and 4,5­
dehydro-L-pipecolate (A4,5-L-PA, 7) served as excellent alternate substrates for L-PADH 
(Table 111.2). Both unsaturated analogs were much more efficiently turned over by L­
PADH as demonstrated by the lower Km and higher Vmax values compared to L-PA. Table 111.1 L-pipecolic acid homologs and N-substituted L-pipecolic acid analogs tested as substrates/inhibitors of L-PADH. 
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Compound  Activity 
L-Pipecolic Acid (1) 
L-Proline (2) 
N-Nitroso-L-Pipecolic Acid (3) 
N-Methyl-L-Pipecolic Acid (4) 
Sarcosine (5) 
Krn=0.88 mM, Vniax= 20 nmolmin-l-me 
At 5 mM: 45% activity relative to L-PA 
At 5 mM: 20% activity relative to L-PA 
Not a substrate, no inhibition 
At 5 mM: 46% activity relative to L-PA 
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N Table 111.2 Dehydro-L-pipecolic acid analogs, oxygen and nitrogen heterocycle analogs of L-pipecolic acid tested as 
substrates/inhibitors of L-PADH. 
HOOC, 
HN 
H 
HN 
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6  7 
0 
8 
Compound 
3,4-Dehydro-L-Proline (6) 
4,5-Dehydro-L-Pipecolic Acid (7) 
(R, S)-1,3-Oxazane-4-Carboxylic Acid (8) 
(S)-Hexahydropyrimidine-4-Carboxylic Acid (9) 
(R, S)-Piperazine-2-Carboxylic Acid (10) 
HOOC,  H  COOH 
HN 
HN 
NH 
9  10 
Activity 
Km= 0.71 mM, Vmax 180 nmolmg-l-min-1 
Km= 0.19 mM, Vmax 88 nmolma1min-1 
Not a substrate, no inhibition 
At 5 mM: 90% of the activity relative to L-PA 
At 5 mM: 28% of the activity relative to L-PA Table 111.3 Sulfur containing heterocycle analogs of L-pipecolic acid tested as substrates/inhibitors of L-PADH. 
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Compound  Activity 
(R)-Thiazolidine-4-Carboxylic Acid (11)  Km 0.83 mM, Vmax= 9.4 nmolmin-l-mg1 
(S)-1,3-Thiazane-4-Carboxylic Acid (12)  Km= 1.5 mM, Vmax= 77 nmolmin-lmg1 
(2R, 45)-2-Methyl-1,3-Thiazane-4-Carboxylic Acid (13a: R=CH3, R'=H)  Not a substrate, no inhibition 
(2S, 4S)-2-Methyl-1,3-Thiazane-4-Carboxylic Acid (13b: R=H, R'=CH3)  Not a substrate, no inhibition 
(35)-1,4-Thiazane-3-Carboxylic Acid (14)  Km=1.1 mM,Vn,ax= 3.1 nmolmin-limal 
(35)-1-0xo-1,4-Thiazane-3-Carboxylic Acid (15a: n=1)  Not a substrate, no inhibition 
(3S)-1,1-Dioxo-1,4-Thiazane-3-Carboxylic Acid (15b: n=2)  Not a substrate, no inhibition 55 
Heteroatoms in the a-position have also been shown to stabilize a carbon-
centered radical intermediate." Therefore, the effect of heteroatom substitution in the 
pipecolate ring was investigated. Substitution of an oxygen atom at position 5 of L-PA 
produced a compound (8) that was not recognized by L-PADH, while nitrogen 
replacement at position 5 of L-PA yielded a good alternate substrate (9) (Table 111.2). 
Moving the nitrogen to the 4 position of L-PA (10) results in a three fold decrease in the 
rate of oxidation when tested at the same concentration. 
A series of sulfur containing derivatives of L-PA were also evaluated for their 
ability to affect L-PADH catalysis. Three thioether derivatives tested (11, 12, and 14) 
served as alternate substrates of L-PADH. Compounds 11 (4-thiaproline) and 12 (5­
thiapipecolate) have the sulfur in the position a to the site of the radical and proved to be 
good substrates with kinetic parameters comparable to those for L-PA (Table 111.3). 
Sulfur substitution at position 4, where the sulfur is now [3 to the radical (14), had no 
effect on Vmax and large decrease in Km, thus yielding a modest substrate. Adding a 
methyl group at position 2 (thiazane numbering) of compound 12 (13a and 13b) 
eliminates binding to the active site, possibly due to steric effects.  Oxidizing the 4­
thiapipecolate 14 to the sulfoxide (15a) or the sulfone (15b) also eliminated the ability of 
the analog to be oxidized by L-PADH or act as an inhibitor. 
Data from kinetics experiments on those L-PA analogs that serve as good 
substrates for L-PADH are presented in double reciprocal plots (1/V vs. 1/S) in Figure 
III.1. Of the these compounds, 03,4-L-proline (6) and A4,5-L-PA (7) were found to be 
excellent substrates of the rabbit dehydrogenase with Kms of 0.71 mM and 0.19 mM, 
respectively, and were turned over by L-PADH at rates substantially greater than that 
observed for L-PA. The 4-thiaproline (11) exhibits kinetic parameters near those of the 
natural substrate while the thiapipecolates 12 and 14 were good-to-modest substrates of 
L-PADH. 
DISCUSSION 
One of the primary reasons for synthesizing the compounds depicted in Tables 
111.1, 1112 and 111.3 was to develop inhibitors of the primate oxidase which may have use 
as pharmacological tools or, possibly, provide leads for therapeutic agents to treat 
convulsive disorders. While rabbit pipecolate dehydrogenase is not a therapeutic target, 
the availability of these substrate analogs provided the opportunity to probe the active 
site topology and catalytic differences of the peroxisomal oxidase and mitochondrial -2.0  2.0  4.0  6.0  8.0  10.0  -5.0  5.0  10.0  15.0 20.0 25.0 30.0 35.0 40.0 
KS]  U[S] 
Figure III.1 Double reciprocal plots of L-PADH with L-PA (1), A3'4 -L -Pro (6), A 4'5-L-PA (7), 4-thiaproline (11), 5-thiapipecolate 
(12), and 4-thiapipecolate (14) as substrates. 57 
dehydrogenase. A comparative summary of the interactions of these compounds with 
Rhesus liver L-PO and rabbit kidney L-PADH is presented in Table 111.4. 
Table 111.4 Comparison of L-pipecolic acid analogs as inhibitors and substrates of L-PO 
and L-PADH. 
Characteristic 
Km (L-PA) 
Vmax(L-PA) 
Alternate Substrates 
Mechanism-Based 
Inactivators 
Reversible Inhibitors 
L-PO 
3.7 mM 
2.1 limolmin-l-mg-1
 
L-proline (2)
 
sarcosine (5)
 
hexahydropyrimidine (9)
 
4-thiapipecolate (14)
 
4,5-dehydro-L-PA (7)
 
5-thiapipecolate (12)
 
N-nitroso-L-PA (3)
 
4-thiaproline (11)
 
2R- methyl -1,3- thiazane (13a)
 
2S-methyl -1,3-thiazane (13b)
 
1-oxo-thiazane (15a) 
L-PADH 
0.88 mM 
0.02 wnolmin-1mg-1 
L-proline (2) 
N-nitroso-L-PA (3) 
sarcosine (5) 
A3,4-L-Pro (6) 
A4,5-L-PA (7) 
hexahydropyrimidine (9) 
piperazine (10) 
4-thiaproline (11) 
5-thiapipecolate (12) 
4-thiapipecolate (14) 
The comparison of L-PO and L-PADH with pipecolic acid as substrate has been 
presented in Chapter II and is also included in Table 111.4.  Other compounds able to 
function as substrates for both enzymes include the L-PA analogs 2, 5, 9, and 14. 
While the above compounds served as alternate substrates for both L-PO and L­
PADH, other L-PA analogs help delineate the differences between the two enzymes. For 
example, A4,5-L-PA (7) is a potent time-dependent inactivator of L-PO with a K1= 0.13 
mM and kinact = 2.0 min-1.81 However, 7 served as an excellent substrate for the rabbit 
enzyme with Km = 0.19 mM and Vmax = 88 nmolmin-1mg-1 and no inactivation was 
detected even when L-PADH was incubated with 5 mM 7 for 24 hours. The lower 
homolog of 7, A3,4-L-Pro (6), is an excellent substrate of both the dehydrogenase and 58 
oxidase, although at very high concentrations some inhibition of the oxidase was detected. 
Compound 12, 5-thiapipecolate, is readily turned over by L-PO, Km = 0.94 mM and 
Vmax = 100 nmolmin-l-mg4 and acts as a poor mechanism-based inactivator K1= 36 mM 
and kinact = 0.06 min-1.76 As is the case with 7, compound 12 reacts with L-PADH only 
as a substrate, Km = 1.5 mM and Vmax = 77 nmolmin-1mg-1. The ability of the rabbit 
dehydrogenase to oxidize these compounds without inhibition is an interesting contrast 
between L-PO and L-PADH. Further studies on the mechanisms of inhibition of the 
oxidase, such as determining if the species responsible for inactivation attacks the flavin 
cofactor or the protein, and sequencing the active sites of both enzymes, may help 
understand these differences. 
Other analogs that highlight differences between the two enzymes include N­
nitroso-L-PA (3), 4-thiaproline (11), the sulfoxide 15a, and the diastereomeric 2-methyl­
1,3-thiazanes 13a and 13b. N-nitroso-L-pipecolic acid (3) is the most potent competitive 
inhibitor yet identified of primate L-PO having a Ki of 0.15 mM.82 Interestingly, 3 
serves as a poor substrate for L-PADH. 4-Thiaproline (11) is another potent reversible 
inhibitor of the monkey oxidase (Ki = 0.30 mM), in surprising contrast to the closely 
related proline (2), 03,4-L-Pro (6), and 5-thiapipecolate (12). However, 11 is readily 
oxidized by L-PADH (Km = 0.83 mM, Vmax = 20 nmolmin-lmg-1). Compounds 13a 
and 13b are also potent competitive inhibitors of L-PO, both exhibiting inhibition 
constants of 0.34 mM, yet 13a and 13b have no effect on L-PADH activity. Finally, the 
sulfoxide derivative of 4-thiapipecolate (15a) is another competitive inhibitor of L-PO (Ki 
= 3.1 mM) which has no effect on L-PADH catalysis. 
In summary, this study describes differences between L-PO and L-PADH in the 
ability to interact with sixteen analogs of pipecolic acid. Five pipecolate analogs serve as 
alternate substrates for both L-PO and L-PADH (Table 111.4) and two derivatives (4 and 
8) do not affect either enzyme, demonstrating a certain degree of similarity in substrate 
recognition beyond that of L-pipecolic acid. More interestingly, other analogs serve to 
illustrate marked differences between the two enzymes. For example, six inhibitors of the 
primate oxidase have been discovered, however no inhibitors of the rabbit dehydrogenase 
have been detected. Two compounds, N-nitroso-L-PA (3) and 4-thiaproline (11) are 
turned over by L-PADH and not by L-PO. The discovery of specific inhibitors of L­
PADH will be an important step in the continuing characterization of these enzymes. 59 
CHAPTER IV
 
CONCLUSIONS 
L-pipecolic acid is an intermediate of lysine metabolism in various organisms 
including bacteria, yeast, fungi and mammals. In mammals L-PA catabolism is unusual in 
that two flavin dependent enzymes have evolved for this process.  In primates the 
enzyme involved in L-PA degradation is a peroxisomal oxidase which has been purified 
and characterized.47 In lower mammals L-PA degradation is catalyzed by a soluble, 
mitochondrial dehydrogenase, but little is known about this enzyme from any source. 
This thesis details the partial purification and characterization of L-PADH from rabbit 
kidney cortex and compares physical and catalytic properties of the rabbit dehydrogenase 
with those of the primate oxidase. 
L-PADH has been purified 300 fold from rabbit kidney cortex. The standard 
purification procedure included homogenization followed by DEAE-cellulose 
chromatography and 45% ammonium sulfate precipitation.  Chromatography on a 
Sephadex G-150 sized exclusion column preceded hydrophobic interaction 
chromatography with  butyl  Sepharose®.  After dialysis, DEAE Fast Flow 
chromatography yielded an enzyme with a final specific activity of 400 nmolmg-ihri. 
A comparison of the enzymes involved in mammalian pipecolate oxidation reveals 
several fascinating differences and similarities; particularly properties such as subcellular 
location, mode of cofactor association and reoxidation, and kinetic parameters. Rabbit 
mitochondrial L-PADH is a soluble enzyme of approximately 50 kDa, while L-PO is a 
monomer at 46 kDa and is a membrane-associated protein located in the peroxisomes of 
primates.47 L-PO has a covalently bound flavin cofactor and molecular oxygen serves as 
the electron acceptor in the catalyzed oxidation of L-PA, the formation of H202 being the 
result.47 L-PADH also utilizes a flavin cofactor, but it requires the addition of an electron 
acceptor such as phenazine ethosulfate in order to reoxidize the flavin back to the 
catalytically active form. It has been suggested that L-PADH eventually shuttles the 
electrons from L-PA through the electron transport chain.45 
Both enzymes have a pH optimum of 8.5 and abstract the pro-6R hydrogen from 
L-PA.72 While the pI of the oxidase is 8.9 indicating that it is a basic protein, the pI of 
the dehydrogenase is estimated to have an acidic isoelectric point at pH 5.6. The Km of 
L-PO for L-PA is four fold higher than that of L-PADH, suggesting that L-PO has a 
lower affinity for L-PA as a substrate. The maximum velocity of L-PO is 100 fold greater 60 
than the dehydrogenase, but it should be noted that the value determined for the 
dehydrogenase is from a non-homogenous enzyme. 
Sixteen L-pipecolic acid analogs were investigated for the ability to serve as 
alternate substrates or inhibitors of the rabbit dehydrogenase and monkey oxidase. Of 
these, five pipecolate analogs serve as alternate substrates for both L-PO and L-PADH 
and two derivatives do not affect either enzyme, demonstrating a certain degree of 
similarity in substrate recognition beyond that of L-pipecolic acid. More interestingly, 
other analogs serve to illustrate marked differences between the two enzymes. For 
example, six inhibitors of the primate oxidase have been discovered, yet no inhibitors of 
the rabbit dehydrogenase have been identified. The discovery of specific inhibitors of L­
PADH will be an important step in the continuing characterization of these enzymes. 61 
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